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Summary 
Due to its high prevalence, -thalassemia in Southeast Asia is a major public health 
problem. Therefore, development of genetic counseling and prenatal diagnosis programs by 
the local government should be a priority. A few limited works have been done to provide the 
groundwork for such programs in North, South and Central Vietnam. In this Doctoral Thesis, 
I determined the spectrum of -thalassemia mutations in two Districs of the Central province 
of Thua Thien Hue (A Luoi and Nam Dong).  
A community-based assessment of thalassemias and hemoglobinopathies was 
conducted to estimate the prevalence of hemoglobinopathies and to assess their molecular 
basis. 1100 participants were enrolled including 83.73% of the minorities (the Taoi, the Pako, 
the Cotu…) and 16.27% of the Kinh.  
The blood samples were firstly screened by complete blood count and osmotic fragility 
test. Hemoglobinopathies were diagnosed by the combination of electrophoresis (Isoelectric 
focusing of native tetramers and Acid Urea Triton-polyacrylamide gel electrophoresis of the 
dissociated globin chains) and High Performance Liquid Chromatography (Cation Exchange 
HPLC and Reversed Phase HPLC). Mutations at the level of β and α globin genes were 
identified after DNA extraction, amplification by PCR of the affected gene, and DNA 
sequencing.  
Four different mutations of the βo-thalassemia type (i.e. characterized by the absence of 
-globin synthesis cis to the mutation) were observed in five subjects: 
- Two of these showed the AAG→TAG nonsense mutation at codon 17, which gives 
rise to a shortened, unstable, globin of 16 amino acid residues. One resulted a compound 
heterozygote in combination with the βE gene (genotype β0/βE) and one was β0/β. 
- One showed the G→T substitution at the IVS-I nt 1, which completely prevents 
splicing of mRNA, combined with the βE gene (genotype β0/βE). Due to the presence of Hb F 
synthesis ameliorating the clinical severity, the  globin genes were also sequenced. The 
C→T substitution in the promoter region, at position -158 with respect to the Cap site of the 
G gene (also known as the XmnI polymorphism) was found in both chromosomes. This is a 
further observation of an increased Hb F synthesis during erythropoietic stress, under the 
control of this mutation.  
- One was the carrier of a four bp deletion (-TTCT) involving codons 41/42 (a 
frameshift  mutation)(genotype β0/β). 
5 
 
Dr. Le Phan Minh Triet:  Hemoglobinopathies in mountainous region of Thua Thien Hue, Vietnam   
Ph.D thesis in Biochemistry and Molecular Biology 
Ph.D School in Biomolecular and Biotechnological Sciences - University of Sassari 
 
- One was the carrier of the G insertion at codons 14/15 (a frameshift mutation) 
(genotype β0/β). 
A total of six samples (three E/, one E/E, two E/o) were examined. Sequencing 
confirmed that the G→A missense substitution at codon 26 (GAG→AAG) of the β globin 
gene is responsible for Hb E.  
The prevalence of the hemoglobinopathies appears to be higher within the minorities 
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1. INTRODUCTION  
 
1.1 Structure and function of human hemoglobins 
 
Hemoglobins (Hb) are globular proteins having the fundamental role to carry oxygen 
(O2) molecules and carbon dioxide (CO2) molecules throughout the body, and it serves also to 
destroy the physiologically important nitric oxide molecule (1). It has evolved to perform its 
transport functions in a highly efficient manner: a. the oxygen affinity of Hb allows nearly 
complete saturation with oxygen in the lungs, as well as efficient oxygen unloading in the 
tissues; b. its affinity increases with oxygenation, resulting in the sigmoid shape of the 
oxygen dissociation curve; and c. deoxy-Hb binds protons and oxy-Hb releases protons. This 
last property, which is known as the “alkaline Bohr effect”, also facilitates oxygen loading in 
the lungs and unloading in the tissues (see Fig. 1 and 2). The Perutz models of oxygenated 
and deoxygenated Hb provide important insights into the structural basis of these three major 
features of the equilibria of oxygen with Hb (2).  
 
 
Figure 1. The sigmoid (cooperative) binding curve of human Hb. The sigmoid binding curve 
can be analyzed as a hybrid curve reflecting the transition from a low-affinity to a high-
affinity state. Because of its cooperative binding, as manifested by a sigmoid binding curve, 
Hb is more sensitive to the small differences in O2 concentration between the tissues and the 
lungs, allowing it to bind oxygen in the lungs (where pO2 is high) and release it in the tissues 
(where pO2 is low). 
 
 
The roles of different parts of the Hb molecule in its equilibria have been deduced from 
its amino acid sequence, its helical conformation, models derived from x-ray crystallography 
7 
 
Dr. Le Phan Minh Triet:  Hemoglobinopathies in mountainous region of Thua Thien Hue, Vietnam   
Ph.D thesis in Biochemistry and Molecular Biology 
Ph.D School in Biomolecular and Biotechnological Sciences - University of Sassari 
 
(3,4) studies of the kinetics of reactions of Hb with ligands (5) and observations utilizing 
nuclear magnetic resonance (6). The concentration of Hb within human red cells is 
extraordinarily high (14 g/dl), and its efficiency as an oxygen carrier is enhanced by its 




Figure 2. Effect of pH on O2 binding to Hb (the Bohr effect). The shift of pH from 7.4 to 7.6 
(as it is in the lungs) increases O2 affinity, whereas the shift to 7.2 (as in the tissues) 
decreases O2 affinity thus facilitating its release. 
 
 
As shown in Fig. 3, Hb molecule consists of four polypeptide subunits, two identical α-
globin chains and two identical β-globin chains, covalently bound with a heme prostetic 
pigments, one in each of the subunits, which are held together by ionic bonds, hydrogen 
bonds, hydrophobic interactions, and van der Waals forces (1). The heme group contains a 
positively-charged iron (Fe
2+
) molecules (Fig. 4) which can reversibly bind to oxygen 
molecules to be transported to the various areas of the body. As the heme groups bind or 
release their oxygen loads, the overall Hb undergoes conformational changes which alters 
their affinity for oxygen (Fig. 1,2). 
The heme group, which is typically hidden within the various subunits, is covalently 
bound, by means of the fifth coordination bond, to a different nitrogen atom belonging to a 
nearby histidine group, the “proximal His” at position 93 of the primary structure (8 of the F 
helix) (2). This histidine chain, together with other hydrophobic residues, stabilizes the heme 
group within each subunit. The O2 molecule binds to the side of the iron ion that is opposite 
of the proximal His by the sixth coordination bond, in front of another His residue which is 
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located at position 64 (E7). His E7 is not directly bound to the heme group nor to the O2 
molecule (it is thus termed as the “distal His”) even though it has a very important function: 
O2 binds to heme with the axis at an angle because the perpendicular arrangement is sterically 




Figure 3. Quaternary structure of Hb. The four subunits are shown in different colors. The 





Figure 4. The heme group. The heme consists of a ring structure, protoporphyrin IX, which 
binds an iron atom in its Fe
2+
 oxydation state. The Fe atom has six coordination bonds, four 
bonded to the flat porphyrin molecule and two perpendicular to it. Fifth and sixth 
coordination bonds are perpendicular to the flat cyclic ring structures; one is bound to a N 
atom of a His residue (the proximal His residue) whereas the other serves as the binding site 
for an O2 molecule. This group is found in myoglobin, Hb, cytochromes, and many other 
heme proteins. 
 
Because His is positively charged, its close proximity to the negatively charged iron ion 
prevents the iron ion from becoming too oxidized, which would inhibit the binding of oxygen 
molecules. This is critical to the Hb’s function of oxygen transport, since oxygen can bind to 
Fe2
+
, but not Fe3
+
. Also, the size, shape, and location of this distal histidine chain limits the 
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amount of CO2 molecules that will bind to the heme group (7). Because the heme group has a 
greater natural affinity for carbon monoxide than for oxygen, the lack of this distal histidine 
chain would allow heme groups to bind significantly more to carbon waste than to oxygen, 
preventing Hb proteins from providing cells with the necessary oxygen molecules for 
metabolic activities. 
After an oxygen molecule binds to one of the heme groups of any subunit, other 
subunits undergo conformation changes exposing their own heme groups, thus giving the 
entire Hb structure greater oxygen affinity (8). The bond between oxygen the oxygen atom 
and the iron ion pulls the iron molecule closer to its heme group, which then pulls the 
proximal distal histidine chain backwards into the Hb molecule (8). This pull creates a strain 
on the other subunits, breaking ionic bonds in such a way that reveals their obscured 
individual heme groups. This positive cooperation allows binding at one subunit to increase 
the binding affinity at other subunits (9). As the result, the whole deoxyHb tetramer (T state) 
changes its conformation collapsing into the oxyHb (R state). A representation of this pulling 




Figure 5. The T → R transition. In these depictions of deoxyHb the α subunits are blue and 
the β subunits are gray. Positively charged side chains and chain termini involved in ion pairs 
are shown in blue, their negatively charged partners in red. The transition from the T state to 
the R state shifts the subunit pairs substantially, affecting certain ion pairs. Most noticeably, 
the His HC3 residues at the carboxyl termini of the β subunits, which are involved in ion pairs 
in the T state, rotate in the R state toward the center of the molecule, where they are no longer 
in ion pairs. Another dramatic result of the T → R transition is a narrowing of the pocket 
between the β subunits. 
 
The behaviour of Hb after binding of protons or CO2, which causes a conformational 
change in the protein facilitating the release of oxygen indicates it is an allosteric protein. The 
sigmoidal (cooperative) curve which makes it efficient in binding (taking up O2 in lungs), and 
10 
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efficient in unloading (unloading O2 in tissues) is a demonstration of an allosteric response to 
the binding of molecules other than O2 in the heme pocket. In people acclimated to high 
altitudes, the concentration of 2,3-Bisphosphoglycerate (2,3-BPG) in the blood is increased, 
which allows these individuals to deliver a larger amount of oxygen to tissues under 
conditions of lower oxygen tension. This phenomenon, where molecule Y affects the binding 




Figure 6. Effect of BPG on oxygen binding to Hb. The 2,3-BPG concentration in normal 
human blood is about 5 mM at sea level and about 8 mM at high altitudes. Hemoglobin binds 
to oxygen quite tightly when BPG is entirely absent, and the binding curve seems to be 
hyperbolic. At sea level, Hb is nearly saturated with O2 in the lungs, but just over 60% 
saturated in the tissues, so the amount of O2 released in the tissues is about 38% of the 
maximum that can be carried in the blood. At high altitudes, O2 delivery declines by about 
one-fourth, to 30% of maximum. An increase in BPG concentration, however, decreases the 




Fetal Hb (HbF, α2γ2), which is found in the developing fetus, binds oxygen with 
greater affinity than adult Hb. This means that the oxygen binding curve for HbF is left-
shifted (i.e., a higher percentage of Hb has oxygen bound to it at lower oxygen tension), in 
comparison to that of adult Hb (HbA). As a result, fetal blood in the placenta is able to take 
oxygen from maternal blood. 
11 
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Hemoglobin also carries nitric oxide (NO) in the globin part of the molecule. This 
improves O2 delivery in the periphery and contributes to the control of respiration. NO binds 
reversibly to a specific Cys residue in globin; the binding depends on the state (R or T) of the 
Hb. The resulting S-nitrosylated Hb influences various NO-related activities such as the 
control of vascular resistance, blood pressure and respiration. NO is not released in the 
cytoplasm of erythrocytes but transported by an anion exchanger called AE1 out of them (10). 
 
1.2. Localization and organization of globin genes 
 
Human Hbs are tetrameric molecules encoded at two separate loci, the -like globin 
gene cluster located on chromosome 11p15.5 (close to the olfactory receptor genes) and the 
-like globin gene cluster on the terminus of chromosome 16p13.3 (close to heterochromatic 
gene encoding a putative RNA-binding protein) (11,12). As shown in Fig. 7 and 8, in each 
cluster the active genes are arrayed on the chromosome in the same order they are expressed 
developmentally: 5’-(embryonic)-G(fetal)-A(fetal)-(minor adult)-(major adult)-3’, and 
5’-(embryonic)-2(fetal and adult)-1(fetal and adult)-3’, respectively. Hemoglobin 
production is characterized by two switches: the production of embryonic Gower1 (22), 
Gower2 (22) and Portland (22) Hbs switches around the first two months of gestation to 
the production of two different fetal Hbs (HbF) (2G2 and 2A2) followed, just before birth, 
to the major adult HbA (22) and minor adult HbA2 (22) tetramers. As the result of the 
second switch, at birth the circulating Hb contains from 70 to 80% of HbF whereas 6 months 
later HbF covers less than 4-5 % of the total. The final adult Hb pattern is reached at 1 year of 
life (Fig. 8). At that time HbA comprises 97%, HbA2 2% and HbF 1%. It is at this stage 
that mutations affecting the  gene become clinically apparent. At birth, HbF contains G and 
A chains in the 70:30 ratio. The switch from fetal to adult Hb production is not complete, so 
that in the small amounts of HbF which persist in adult life the proportion of the two chains 
reverses to 40:60. The switch from fetal to adult Hb is not due to changes in stem cell 
populations but rather to changes in programs of gene expression occurring in the progeny of 
a single stem cell population. All adults have residual amounts of HbF, present in a subset of 
erythrocytes called F-cells which also contains HbA. The levels of HbF and F-cells in adults 
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1.2.1 Detailed chromosomal organization of the human globin genes.  
Two other α-like globin genes have been identified and characterized in the α-globin 
gene cluster, but their roles, if any, in encoding globin polypeptides are still uncertain. The θ-
globin gene located to the 3’ or C-terminal side of the duplicated α-globin genes (16). It is 
more closely related to the α-globin genes than to the ζ-globin genes and is expressed at low 
levels in erythroid cells (17,18). Clear homologs to the θ-globin gene are found in the 




Figure 7. Basic organization of human - and -globin gene complexes and expression of the 
globin genes during ontogenesis. The locations of the -globin gene complex very close to 
the telomere of the short arm of chromosome 16 and the -globin gene complex on the short 
arm of chromosome 11 are shown. The genes are shown as boxes, named according to the 
globin polypeptide that is encoded. In both diagrams, the 5’→3’ transcriptional orientation is 
from left to right. The orientations with respect to the centromere (CEN) and telomere (TEL) 
are opposite; the -like globin genes are transcribed toward CEN whereas the -like globin 
genes are transcribed toward TEL. The composition of Hb produced at progressive 
developmental stages is given between the clusters. The stage specific interaction between the 
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Figure 8. Globin chains production during ontigenesis. The production of embryonic Gower1 
(22), Hb switches around the first two months of gestation to the production of HbF (22) 




The μ-globin gene is located just 3’ of the ψζ1-globin pseudogene (19, 20); it was 
initially called ψα2 (21) but with more accurate sequencing it is clear that this gene does not 
contain mutations that would render it inactive. It is a distant relative, being equally divergent 
from both α-globin and ζ-globin genes. Both the θ-globin gene and the μ-globin gene are 
transcribed and spliced in erythroid cells, albeit at much lower levels than the α-globin gene. 
Curiously, no Hb containing the θ-globin chain or the μ-globin chain has been identified, 
even by the sensitive mass spectrometry (20). Furthermore, the predicted structure of the θ-
globin chain suggests that it would be unlikely to function normally as a Hb subunit (22). 
Thus these genes remain a puzzle. They tend to be retained over mammalian evolution, hence 
indicating constraint for some function. They are expressed at the RNA level but do not 
appear to be translated into a polypeptide. Perhaps they or their RNA transcripts play some 
role that has yet to be discovered. 
 
1.2.2 Structure of globin genes  
The coding region of each globin gene in humans (as well as in other vertebrates) is 
interrupted at two positions by tracts of noncoding DNA which were called intervening 
sequences (IVSs) or introns (23). In the β-like globin genes, the introns interrupt the sequence 
between codons 30 and 31 and between codons 104 and 105; in the α-globin gene family, the 
14 
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IVSs interrupt the coding sequence between codons 31 and 32 and between codons 99 and 
100 (Fig. 9). Interruptions due to introns occur at precisely the same position in the aligned 
primary sequence of the α- and β-globin chains. It has been hypothesized that the presence of 
the introns at these positions predates the separation of α-globin and β-globin genes, occurred 
in an ancestral vertebrate about 500 million years ago (24). The first IVS (IVS-1) is smaller 
than the IVS-2 in both α- and β-globin genes, but IVS-2 of the human β-globin gene is much 
larger than that of the α-globin gene. 
The intron sizes of the ζ-like globin genes differs from that of the α-like globin genes 
since the introns in the α and ψα genes are small, fewer than 150 base pairs (bp), than those of 
the ζ and ψζ genes (25). The first introns of the ζ and ψζ genes are much larger than their 
second introns. The IVSs sequences interrupting the coding sequences of structural genes are 
removed during maturation of mRNA. Figure 9B shows that IVSs are transcribed into globin 
precursor mRNA (26), and next excised in such a way that the proper ends of the coding 
sequences joins to give rise the mature mRNA (27). This posttranscriptional processing of 
mRNA precursors has been termed “splicing”. A crucial prerequisite for the proper splicing 




Figure 9. Structure and expression pathway of globin genes. A. General structure of globin 
genes. The coding sequences are separated by two IVSs (white boxes) into three exons. The 
first exon has a short 5’ untranslated region (UTR, gray box) followed by a coding region 
(black box). The central exon codes for protein, while the third ends with a 3’ UTR. The sizes 
of the boxes indicate the size of the tracts of the genes. Codon numbers are also given. Under 
the second intron of the -globin gene are indicated the “consensus sequence”. These are 
critical for the correct splicing process. Similar sequences are present in all introns. The 
vertical arrows indicate the splice site junctions within the consensus sequences where 
cleavage occurs during the process of cutting the introns and joining exons. 
B. The pathway for expression of globin genes. The RNA transcript is shown with short 
boxes corresponding to the UTRs (gray), coding regions (black) and introns (white), with 
processing and splicing steps occurring in the nucleus to form mRNA (15).  
15 
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Two different “consensus sequences” have been almost universally found at the 5’ 
(donor) and 3’ (acceptor) splice sites of introns (28). These are shown in Figure 9A, with the 
consensus surrounding the “branch point” A involved in the initiation of splicing. The 
doublets GT and AG (shown in boldface) at the 5’ and 3’ ends, respectively, of the intron, are 
invariant and thought to be absolutely required for proper splicing. This is referred to as the 
GT-AG rule. Mutations that alter those dinucleotide sequences or create similar consensus 
sequences at new sites in a globin gene are known determine abnormal processing of mRNA 
precursors thus representing the molecular basis for some types of thalassemia.  
The globin genes nomenclature has been recently standardized following the Guideline 
for Human Gene Nomenclature. It is showed in Table 1. 
 
Table 1. Nomenclature of the globin genes* 

Gene    Nomenclature 

 
           HBZ
    HBA1 
2          HBA2 
θ          HBQ 
    HBE 
G
    HBG2 
A
    HBG1 
    HBB 
    HBD 

*Aguileta G., Bielawski J.P., Ziheng Y. Proposed nomenclature for the  and   
globin gene family. Genes Genet. Syst. 81, 367-371, 2006. 
 
 
1.2.3. Regulation of globin genes expression 
Studies conducted during the past three decades have revealed much about the 
regulation of the human globin genes. These include information about DNA sequences 
needed in cis such as: promoters, upstream regulatory sequences, proximal enhancers and 
distal enhancers. The knowledge on these regulatory elements not only facilitated a better 
comprehension on the molecular basis of hemoglobinopathies but also was the most useful 
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Promoters 
A promoter is the DNA sequence needed for accurate initiation of transcription. It is a 
DNA segment that interacts with RNA polymerase II and its accessory factors (such as TFIID 
and TFIIB) to determine the start site of transcription; this is the basal promoter (29). Five 
motifs have been associated with basal promoters, and these are found in the promoters of 
human globin genes (Figure 10.A). They include the familiar TATA box to which TBP binds, 
along with the BRE to which TFIIB binds and the Inr and DPE motifs to which components 
of TFIID binds (29). 
Efstratiadis et al. (30) revealed the presence of the ATAAA sequence (motif) about 25-
30 bp 5’ to the start site of transcription of the globin genes, by far considered the most 
convincing evidence in its consensus role. More recent studies on other promoters revealed 
the presence and roles of additional motifs close to the start site of transcription. Matches to 
these motifs can be found readily at the appropriate positions in the human globin genes (Fig. 
10.A). Except BRE, each of he motifs in Fig. 10A has been implicated in function by the 
discovery of a mutation in cases of β-thalassemia (from now on: -thal). Every base in the 
TATA box has been altered in one or another thalassemia, and mutations in Inr, MTE and 
DPE also are associated with this syndrome.  
Upstream regulatory sequences 
Adjacent to the basal promoter is the upstream regulatory region (29), which runs from 
about positions -40 to -250 (Figure 10). The CCAAT box appears to be the only one motif 
highly expressed in this region. Different proteins bind to this motif (30), and it has been 
implicated in promoter function because of its presence in many promoters and the results of 
mutagenesis and binding studies (31).  
Two other motifs which are found to bind to proteins are the CACC box, which is 
bound by transcription factors in the Krüppel-like zinc finger class (KLF) and the WGATAR 
which is the binding site for GATA-1 and related proteins (32,33). Mutations in almost every 
position in the proximal CACC box have been associated with β-thal.  
Proximal Enhancers 
The enhancers are sequences that increase the activity of promoters; they can be located 
on either side of a gene or internal to it, and they can act at considerable distances from genes 
(34). Two enhancers have been found close to genes in the β-globin gene cluster, one that is 
3’ to HBB and one that is 3’ to HBG1 (Figure 10.A). In both cases the enhancers are less than 
1 kb downstream of the polyA additional signal for the respective genes. The HBG1 enhancer 
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was discovered as the only DNA segment in a 22kb region surrounding the γ-globin genes for 
DNA segments that boosted expression of a reporter gene driven by a γ-globin gene promoter 





Figure 10. Motifs and binding sites in cis-regulatory modules of globin genes. (A) Motifs in 
the basal promoter, as review by Maston et al. (29). Numbers along the top are relative to the 
transcription start site as +1, and ATG denotes the translation start site. Corresponding 
positions in the globin genes are given for each motif, followed by the consensus derived for 
the globin genes. Some ambiguous nucleotides are indicated. (B) Motifs in the regulatory 
regions immediately upstream of the basal promoters. Motifs are indicated by sequence 
(CCAAT, CACC, and GATA), by the name (βDRE, αIRE, γPE, OCT) or by the protein name 
followed by “bs” for “binding site” (BP2bs, NF1bs, BB1bs). Boxes found in several upstream 
regions are shaded. The boxes were placed in the correct order but spacing is not indicated. 
The thick line for the HBA upstream regions (both HBA1 and HBA2) denotes that it is a CpG 
island. (C ) Motifs in the proximal enhancers. (D) Motifs in distal positive regulators, 
including three hypersensitive sites of the β-globin LCR and HS-40 for the α-globin gene 
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Distal Enhancers 
Both the α-like and β-like globin gene clusters are regulated by distal control regions. 
The β-like globin cluster is regulated by the distal LCR (36), and the α-like globin gene 
cluster is regulated by HS-40 (37). In both cases, deletion of the distal control region is 
associated with thalassemia. Without the LCR, erythroid expression of a β-globin transgene is 
not seen in all mouse lines (38), whereas with the LCR, the β-globin transgene is expressed at 
a high level in erythroid cells in almost all mouse lines, indicating strong enhancement and a 
reduction in position effects (39). A schematization of how an enhancer might affect gene 
transcription by bringing distal DNA is showed in Figures 11 and 12.  
A clear picture on the mechanism of gene regulation was described in a Melanesian 
variant of the -thal due to a single-nucleotide polymorphism located between the adult -
globin genes and their enhancers. The finding that this mutation creates a novel promoter 
provides support for a mechanism of gene regulation by facilitated chromatin looping (40). 




Figure 11. An enhancer might affect gene transcription by bringing distal DNA (perhaps 
thousands of base pairs away from the start site of transcription) close to the promoter for a 
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Figure 12. Possible mechanism for the downregulation of -globin gene expression in 
hemoglobin H disease. (a) Schematic diagram of the human -globin locus. The -globin 
gene (light-blue oval) is expressed in the embryonic stage of development and is silenced at 
around 6 to 8 weeks of gestation. The -globin genes (dark-blue ovals) are activated in fetal 
liver, and then in bone marrow in the adult. The physiological levels of -like globin gene 
expression depend on the actions of upstream enhancers (HS-33 and HS-40), mainly HS-40, 
which is located 40 kb 5’ of the -gene. The single nucleotide polymorphism (SNP) 195 is 
shown as a green circle. (b,c) An interpretation for the SNP195 promoter-induced 
downregulation of the -globin genes. The effective interaction between proteins bound by 
the enhancer (depicted as a red circle) and the -globin genes is essential for their high-level 
expression, and is accomplished by chromatin looping. (b) In the normal locus the SNP195 
region is lightly acetylated and chromatin flexibility favors interaction between the enhancer 
and the 1- and 2-genes. (c) When the SNP195 promoter site (green circle) is activated in 
HbH disease, histone acetylation is increased and the chromatin becomes more flexible as a 
consequence, resulting in a change in loop size. This change means that the enhancer now 




1.3. Disorders of the synthesis of hemoglobin 
 
The study of the disorders of the synthesis of Hb is considered a paradigm for 
understanding insights into the cellular, molecular biology and pathophysiology of inherited 
genetic disorders. As many as 1570 disorders of Hb synthesis and of the structure have been 
so far identified and characterized. These are collected, and continuously updated, in the 
Globin Gene Server (42). Study of these disorders has established the principle of how a 
mutant genotype can alter the function of the encoded protein, which in turn can lead to a 
distinct clinical phenotype. Genotype/phenotype correlations have, in turn, provided 
important understanding of pathophysiological mechanisms of disease.  
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1.3.1. Classification of hemoglobinopathies 
Disorders affecting the synthesis of the globin chains are classified into two categories: 
qualitative Hb-pathies (also known as hemoglobinopathies, Hb-pathies), and quantitative Hb-
pathies (also known as thalassemias). Rarely, a single mutation affects both the structure and 
expression level of the affected gene, and these have been called quali-quantitative Hb-
pathies or thalassemic hemoglobinopathies. Thus the latter were better classified as 
“dominant” β or -thal (41).  
The hemoglobinopathies (or qualitative Hb-pathies) thus refer conditions characterized 
by the inheritance of mutated Hbs which contain  or  globin chains with changes at the 
level of the primary structure of globin which is synthesized at a normal rate. The affected Hb 
is also called “variant Hb” or “variant globin”. In most cases these Hb-pathies are due to a 
point mutation at the level of the structural gene which changes the meaning of the codon 
thus replacing the amino acid with a different one (missense mutations). Some sequence 
changes have little or no effects on Hb functions but are useful polymorphisms for genetic 
studies. A large number, however, are characterized by an altered Hb function (43). Variant 
Hbs are designated by letters of the alphabet or by the place names where the condition was 
first discovered. Even though researchers have identified more than 1100 structural 
hemoglobin variants, only three (Hb S, Hb C, and Hb E) are widespread. The homozygous 
state for the Hb S (sickle cell) gene results in sickle cell anemia, whereas the compound 
heterozygous state for the sickle cell and Hb C genes results in Hb SC disease. Hb SC 
disease, although milder, also has important public health implications. Hb E, the commonest 
variant globally, is innocuous in its heterozygous and homozygous states, but since it is 
synthesized less effectively than Hb A, it interacts with -thal to produce an extremely 
common condition called Hb E -thal, which is an increasingly important health burden in 
many parts of Asia.  
As shown in Table 2, which is the updated summary of the 1578 Hb variants so far 
identified, all the  and non- globin genes are subjected to mutations: 325 + 393 concern the 
 globin genes, 828 the  gene, 105 the , 58 the A and 69 the G genes, whereas 51 could be 
considered due to mutations disturbing both the primary structure of the globin chain and the 
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Table 2. Human Hemoglobin Variants 









 globin genes having altered 





The thalassemias constitute a heterogeneous group of naturally occurring, inherited 
mutations characterized by abnormal globin gene expression resulting in total absence or 
quantitative reduction of - or -globin chain synthesis in human erythroid cells. -Thal is 
associated with absent or decreased production of -chains, whereas in the -thal, there is 
absent or decreased production of -chains. In those cases in which some of the affected 
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globin chain is synthesized, early studies demonstrated absence of an amino acid substitution. 
The thalassemia gene appears to be allelic with the structural gene encoding - or -globin 
(41).  
Increase the knowledge of the molecular basis of -thal has followed and depended on 
progress and technical advances in the fields of biochemistry and molecular biology. In 
particular, recombinant DNA and polymerase chain reaction-based technologies (PCR) have 
contributed to a virtual explosion of new informations on the precise molecular basis of  most 
 
Table 4. Classification of hemoglobin disorders 
I. QUANTITATIVE DISORDERS OF GLOBIN 
CHAIN SYNTHESIS/ACCUMULATION 
The thalassemia syndromes 
A. β-Thalassemia 












“Dominant” β-thalassemia (structural variants with β-
thalassemia phenotype) 





Deletions of α-globin genes: 
One gene: α+-thalassemia 
Two genes in cis: α0-thalassemia 
Two genes in trans: homozygous α+-thalassemia 
(phenotype of α0-thalassemia) 
Three genes: HbH disease 
Four genes: Hydrops fetalis with Hb Bart's 
Nondeletion mutants: 
Hb Constant Spring 
Other 
Due to mutations of the ATRX transcription factor gene 
on chromosome X 
α-Thalassemia associated with myelodysplastic 
syndromes (ATMDS): 
Due to mutations of the ATRX gene 
C. De novo and acquired α-thalassemia 
α-Thalassemia with mental retardation syndrome 
(ATR): 
Due to large deletions on chromosome 16 involving 
the α-globin genes 
II. QUALITATIVE DISORDERS OF GLOBIN 
STRUCTURE: STRUCTURAL VARIANTS OF 
HEMOGLOBIN 
A. Sickle cell disorders 
SA, sickle cell trait 
SS, sickle cell anemia/disease 
SC, HbSC disease 
S/β thal, sickle β-thalassemia disease 
S with other Hb variants: D, O-Arab, other 
SF, Hb S/HPFH 
B. Hemoglobins with decreased stability 
(unstable hemoglobin variants) 
Mutants causing congenital Heinz body hemolytic 
anemia 
Acquired instability-oxidant hemolysis: Drug-
induced, G6PD deficiency 
C. Hemoglobins with altered oxygen affinity 
High/increased oxygen affinity states: 
Fetal red cells 
Decreased RBC 2,3-BPG 
Carboxyhemoglobinemia, HbCO 
Structural variants 
Low/decreased oxygen affinity states: 





Cytochrome b5 reductase deficiency 
Acquired (toxic) methemoglobinemia 





Ref. Forget and Bunn (41) 
forms of thalassemia. Table 4 shows a comprehensive classification of the several, different, 
Hb disorders. The growth of this knowledge has matched the acquisition of detailed 
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information on the structure, organization, and function of the normal human globin genes. 
As a result, there have been a progressively clearer and increasingly complex picture of the 
molecular pathology of this group of genetic disorders. A major conclusion that was drawn 
was that a relatively limited number of phenotypes can result from a surprisingly large 
number of varied genotypes.  
 
1.3.2. Pathophysiology of hemoglobinopathies 
The causes for the anemia observed in the different forms of thalassemia are primary 
and secondary. In -thal, a reduced synthesis of -globin chains of Hb A (22) will result in 
an overall deficit of Hb accumulation in erythrocytes and cause a hypochromic, microcytic 
anemia with a low mean corpuscular hemoglobin concentration in affected erythrocytes. This 
is the case in both the heterozygous and homozygous states. In the homozygous state, 
however, another pathophysiological process worsens the anemia and is responsible for the 
major clinical manifestations in the syndrome referred to as -thal major or Cooley’s anemia.  
The continued synthesis in normal amounts of normal -globin chains results in the 
accumulation, within the erythroid cells, of excessive amounts of  chains. These chains 
cannot find complementary globin chains with which to bind, these chains form insoluble 
aggregates and precipitate within the cell, causing membrane damage and premature 
destruction of the red cells. The -chain aggregates are called inclusion bodies or Heinz 
bodies. The process of inclusion body formation occurs not only in mature erythrocytes, but 
in particular in the erythroid precursor cells of the bone marrow. As a result, there is 
extensive intramedullary destruction of erythroid precursor cells, a process that is called 
“ineffective erythropoiesis”. The severity of the clinical manifestations in -thal generally 
correlates well with the amount of the free -chain pool and the degree of - to non--globin 
chain imbalance. Therefore, the fortuitous coinheritance of -thal together with homozygous 
-thal reduces the degree of - to non -globin chain imbalance and leads to a milder clinical 
course (1). Similarly, coinheritance of β-thal with conditions that are associated with 
increased levels of synthesis of -chains of HbF (22) leads to less imbalance between - and 
non -globin chain synthesis, resulting in decreased formation of -chain inclusion bodies, 
increased effective production of red cells, and their prolonged survival in the circulation. The 
clinical course in most cases of homozygous -thal is severe. Although anemia is not evident 
at birth, severe hypochromic, microcytic, hemolytic anemia develops during the first year of 
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life and a regular transfusion program must be undertaken to maintain an adequate circulating 
hemoglobin level.  
Owing to changes in the philosophy and practice of transfusion therapy, the clinical 
manifestations of homozygous -thal in childhood have changed considerably over the past 
decades. With modern transfusion therapy, most children will develop normally, with few or 
no skeletal abnormalities, and will have a reasonably good quality of life. To avoid iron 
overload from transfusional hemosiderosis, transfusion therapy is usually coupled with a 
vigorous program of iron chelation, typically using parenterally administered desferrioxamine 
and more recently, orally effective iron-chelating agents. Although it is possible to maintain 
iron balance with such a management program, compliance is often difficult to realize. Iron 
overload eventually develops in most patients and is the major cause of morbidity and 
mortality in young adults. The one therapy that is curative is bone marrow or stem cell 
transplantation, which is being increasingly practiced when feasible. The hope for the future 
is the development of even more effective oral iron-chelating agents and improved 
approaches to gene therapy.  
Studies of the molecular basis of -thal have demonstrated that the gene defects 
responsible for the disorder are quite heterogeneous (41). In contrast to -thal, in which 
deletions in the -globin gene cluster account for most of the mutations, the molecular 
defects associated with -thal are usually point mutations involving only one (or a limited 
number of) nucleotide(s), but resulting in a major defect of -globin gene expression either at 
the transcriptional or posttranscriptional level, including translation. 
Practically every conceivable type of defect in gene expression has been identified in 
one form or another of -thal. Over 200 point mutations have been identified. Some deletion 
types of -thal have also been described. In cases of -thal in which -globin gene expression 
is not totally absent (so-called +-thal), the -chain that is synthesized is usually structurally 
normal. There is a syndrome called dominant -thal in which a highly unstable, structurally 
abnormal -globin chain is synthesized, resulting in inclusion body formation in the 
heterozygous state. The coinheritance of HbE (22 GluLys) with -thal is very prevalent 
in Southeast Asia and results in markedly variable and heterogeneous clinical manifestations, 
the basis for which is poorly understood. Finally, there are a number of -thal-like disorders, 
called -thal and hereditary persistence of fetal hemoglobin (HPFH), that are distinguished 
from the more typical forms of -thal by the presence of a substantial elevation of HbF in 
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heterozygotes, as well as in homozygotes and compound heterozygotes. These disorders are 
usually due to deletions of different sizes involving the -globin gene cluster, although 
nondeletion types of these disorders have also been identified.  
The great heterogeneity of molecular lesions causing -thal may appear at first glance 
to create insurmountable problems in putting this knowledge to practical use in the form of 
prenatal diagnosis and genetic counseling.  
The availability of rapid and accurate PCR reaction-based assays for the detection of 
specific mutations in small samples of DNA has resulted in a number of surveys for the 
detection of the prevalence of different -thal mutations in various population groups. The 
results of these surveys indicate that a given mutation is usually found only within one racial 
group and not another. Furthermore, a small number of different mutations, usually five or 
six, frequently accounts for 90% or more of the cases of -thal in a given population group. 
Thus, it is possible to devise efficient and precise prenatal diagnosis programs using DNA-
based approaches. Such programs have led to a striking decrease in the number of births of 
infants with homozygous -thal in many countries where the disease is prevalent. 
 
1.4. Molecular basis of thalassemia 
 
As already mentioned, the -thal are characterized by a quantitative reduction in the 
production of -globin chains of HbA. More than 200 -thal alleles have now been 
characterized (42) involving mutations affecting any of the steps in the transcription of the -
globin gene, posttranscriptional processing of its pre-mRNA, or the translation of its mRNA 
into protein. The vast majority of simple -thal are caused by point mutations within the gene 
or its immediate flanking sequences, although small deletions involving the  gene may also 
occur. In the case of -chain production is totally abolished by the mutation, it is referred to 
as o-thal, whereas reduced output of -chains (of normal structure) produces +-thal, with 
the mildest forms sometimes referred to as ++- or “silent” -thal. These common forms of -
thal are inherited as mendelian recessives. Some structurally abnormal -chain variants are 
also associated with quantitative deficiencies of -globin chain production and have a 
phenotype of -thal, in which case they are referred to as “thalassemic hemoglobinopathies,”. 
This is the case, for example, of HbE (26 Glu→Lys). In others, the -globin variants are so 
unstable that they undergo very rapid postsynthetic degradation giving rise to a functional 
deficiency. These hyperunstable -chain variants act in a dominant negative fashion, causing 
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a disease phenotype even when present in the heterozygous state, and hence have been 
referred to as “dominantly inherited -thal.” (46).  
The -thal and hereditary persistence of fetal hemoglobin (HPFH) are disorders related 
to the -thal that also involve down-regulation of -globin gene expression. In -thal the  
gene is also affected and there is variable compensation from increased HbF production. 
These disorders result from more extensive deletions within the -globin gene cluster, as do 
the deletion forms of HPFH in which HbF compensation is sufficient to minimize 
hematological abnormalities. Other forms of HPFH result from mutations in the promoters of 
the -globin genes that not only increase HbF production in adult life but are accompanied by 
reduced -chain production.  
In this section, the molecular mechanisms underlying the different types of-thal are 
described.  
The common denominator is absent or decreased synthesis of -globin chains, resulting 
in the accumulation of excess -globin chains that are responsible for the pathophysiology of 
the disorder. The severity of the phenotype is usually related to the degree of imbalance 
between - and non--globin chain synthesis, and the size of the free -chain pool. Hence 
severity is related to the type of  allele (o, +, ++), ameliorated by an interacting -thal (by 
reducing the -chain excess) and any increased production of -chains (that decrease the 
excess of free a -chains by binding to them to form HbF).  
 
1.4.1. The -thalassemia 
1.4.1.1. Nondeletion types of -thalassemia  
These defects account for the majority of the -thal alleles. They involve single base 
substitutions, small insertions or deletions within the gene or its immediate flanking 
sequences, and affect almost every known stage of gene expression. Allele frequency varies 
widely from one population to another though within any population there are usually a small 
number of common alleles together with many alleles that are rare for that population. These 
defects are listed in Table 5 according to the mechanism by which they affect gene function: 
transcription, RNA processing, or RNA translation. The mutations are continuously updated 
and the list is accessible electronically through the Globin Gene Server Website (42). 
Heterozygotes have minimal anemia but hypochromic (mean corpuscular haemoglobin, 
MCH, 18–24 pg), microcytic (mean corpuscular volume, MCV, 65–80 fL) red blood cells. 
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They are characterized by an increased proportion of HbA2 (normal <3.2%, -thal trait 
3.5%–6.0%), and HbF levels that vary from normal (<1.0%) to slightly raised (1.0%–3.0%). 
Transcriptional mutations 
As shown in Table 5, as many as 26 mutations involve the conserved 100 bp DNA 
sequences that precede the site of the initiation of transcription and represent the -globin 
promoter (including the functionally important CACCC, CCAAT, and ATAA boxes), 
whereas 8 mutations are described in the stretch of 50 nucleotides in the 5’ untranslated 
region (UTR). These mutations affect transcription of the gene giving rise to mild +-thal. 
Mutations in all of the three conserved sequence motifs in the  promoter, the two CACCC, 
CCAAT, and ATAA boxes, have been identified in different patients with -thal (47). These 
defects have been described in diverse ethnic groups, with ethnic variation in phenotype. 
Black individuals homozygous for the -29 A→G mutation have an extremely mild disease 
(48), whereas a Chinese individual homozygous for the same mutation had thalassemia major 
(49).The cause of this remarkable difference is not known but may be related to the different 
chromosomal backgrounds on which the apparently identical mutations have arisen or to the 
C-T polymorphism at position -158 upstream of the 
G-globin gene (Xmn1-G site), which is 
associated with increased HbF production under erythropoietic stress. The Xmn1-
G site is 
present in the  chromosome carrying the −29 A→G mutation in Blacks but absent in that of 
the Chinese (50). The C-T mutation at position −101 to the-globin gene appears to cause an 
extremely mild deficit of -globin. In fact, heterozygotes are “silent” with borderline 
reduced/normal red cell indices (51,52). 
Since the CAP +1 A-C mutation was described (53) 7 additional mutations in the 5’ 
UTR stretch have been characterized. The heterozygotes for this class of mutations are silent, 
with the hematological indices of  thal carrier. It is possible that the CAP mutation decreases 
-globin gene transcription or decreases the efficiency of posttranscriptional addition of m7G 
(capping) and mRNA translation.  
Mutations of the splice site junction affecting RNA processing 
The process of the IVSs excision from the precursor mRNA to produce functional 
mRNA (splicing) must be very accurate. Sequences critical in the splicing process are the 
invariant dinucleotides GT at the 5’ (Donor) and AG at the 3’ (Acceptor) splice junctions in 
the introns. Table 5 shows that 27 mutations affect either of the invariant dinucleotides in the 
splice junction completely abolish normal splicing and produce the phenotype of o-thal. 
28 
 
Dr. Le Phan Minh Triet:  Hemoglobinopathies in mountainous region of Thua Thien Hue, Vietnam   
Ph.D thesis in Biochemistry and Molecular Biology 
Ph.D School in Biomolecular and Biotechnological Sciences - University of Sassari 
 
These mutations can be base substitutions that change one or the other of invariant 
dinucleotides or short deletions that remove them. Genes bearing these mutations appear to 
transcribe normally and, although some alternative splicing occurs using “cryptic” donor or 
acceptor sites, the misspliced mRNA do not translate into functional -globin.  
Mutations of splice site consensus sequence affecting RNA processing 
The invariant “donor” and “acceptor” dinucleotides essential for the splicing of introns 
are flanked by sequences that are rather well conserved and a consensus sequence can be 
recognized at the exon-intron boundaries. These encompass the last three nucleotides of the 
exon and the first six nucleotides of the intron for the 5’ donor site; and the last 10 
nucleotides of the intron and the first nucleotide of the exon for the 3’ acceptor site. Thirteen 
different mutations (Table 5) within the consensus sequences at the splice site consensus 
sequence have been demonstrated to reduce the efficiency of normal splicing to varying 
degrees and produce a -thal phenotype ranging from mild to severe. Mutations at IVS1 
position 5, G→C, T, or A considerably reduce splicing at the mutated donor site compared 
with normal. As shown in Fig. 13, the mutations appear to activate the use of three otherwise 
“cryptic” donor sites (i.e. sequences that mimic the consensus sequence for a splice site but 
are not normally used). Two of these are in exon 1, and one in IVS1 (54). On the other hand, 
the substitution TC in the adjacent nucleotide, IVS1 position 6, only mildly affects normal 
RNA splicing even though it activates the same three cryptic donor sites as seen in the IVS1–
5 mutants (54). Although the IVS1-6 TC mutation is generally associated with milder -
thal, it has been shown that in some cases apparently identical mutations can be severe (55) 
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Figure 13. Alternative splicing of precursor -globin mRNA resulting in +-thal associated 
with the IVS1–110 G→A mutation. The G→A substitution at position 110 creates an AG 
dinucleotide within a potential 3’ acceptor splice site resulting in approximately 90% mRNA 
aberrantly spliced and 10% normally spliced (45). 
 
 
Mutations creating new alternative splice sites in introns 
Splicing mutation may be due also to base substitutions in IVS that generate new 
splicing signals, which are alternative to the normal splice sites. Six mutations have been 
identified in the -globin gene: two in IVS1 and four in IVS2 (Table 5)(45). Depending on 
the site and nature of the mutation, the phenotype may be either + or o-thal. The splicing 
mutation at position 110 of IVS1 was the first base substitution identified in a -thal gene 
(56,57). This mutation is one of the most common type of -thal in the Mediterranean 
population. The mutation is a G→A substitution that creates an acceptor AG in a positive 
consensus sequence environment, 19 bp 5’ to the normal acceptor AG of IVS1 (Fig. 13). This 
newly created alternative splice site is preferentially used in 80%–90% of the transcripts, 
whereas the normal splice site is used in only 10%-20% of the transcripts (58,59), thus giving 
the phenotype of + thal.  
Another -thal gene with a T→G substitution in position 116 of IVS1, leads to a newly 
created 3’ acceptor site. In this case, the normal acceptor sequence, although intact, is not 
used, and little or no normal  mRNA is produced resulting in a o-thal phenotype (60). 
Three other -thal genes are due to substitutions within IVS2 that generate new donor sites 
(Fig. 14). They include the IVS2 position 654 C→T, 705 T→G, and 745 C→G. In each case, 
an upstream acceptor site at position 579 is activated such that the normal 5’ donor site at 
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exon 2/IVS2 is spliced to the activated site at position 579 and the newly created donor site is 
spliced to the normal 3’ acceptor site at IVS1/exon 3. This two-stage splicing results in the 
retention of 73 bp of IVS2 in the misspliced  mRNA for the IVS2 654 mutation. Variable 
amounts of splicing from the normal donor to the normal acceptor also occurs, resulting in 
phenotypes that range from + to o-thal. Several individuals heterozygous for the IVS2 654 
C-T mutation with a severe phenotype have been described (50). The unusually severe 
disease in these individuals is thought to result from the accumulation of the misspliced 
mRNA, which was predicted to translate into a highly unstable  chain variant with a 
dominant negative effect. Some normal splicing of IVS2 occurs; therefore, this mutation 





Figure 14. Alternative splicing of precursor -globin mRNA due to three base substitutions; 
C→T at position 654, T→G at position 705, and C→G at position 745 in IVS2 of the -
globin gene. Each of these mutations creates a 5’ donor site that is preferentially spliced to the 
normal 3’ acceptor site, whereas the same acceptor site is activated upstream at position 579 
in IVS2 and spliced to the normal donor site at the exon 2–IVS2 junction. This results in the 
incorporation of 73, 121, and 151 bp of IVS2 into the aberrantly spliced mRNA associated 
with each of the different IVS2 mutations, respectively (45). 
 
 
Mutations creating alternative splice sites in exons 
Four mutations have been identified in exon 1 that are associated with activation of 
cryptic or alternative splice sites (50). Three modify the cryptic splice site spanning codons 
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24-27 in exon 1 so that it closely resembles the physiological consensus splice sequence 
AAGGTGAGT and activates it. The reduction in normal splicing is the molecular cause for 
the mild +-thal phenotype of these variants, including the E allele which is particularly 
common in Southeast Asia where it can reach a frequency of 75%. Interaction of the E allele 
with -thal genes is responsible for a large proportion of the thalassemia major observed in 
Southeast Asia. Similarly, the A→G mutation in codon 19 activates another cryptic donor site 
spanning codons 17–19 in exon 1 resulting in a reduced level of normally spliced  mRNA 
that contains the codon 19 mutation encoding Hb Malay (61).  
Mutations modifications causing abnormal posttranscriptional modifications 
The nascent globin mRNA molecule is submitted to posttranslational modifications at 
both of its ends: a methylated ’m7G’ cap structure is added at the 5’ end, and a poly adenilic 
(A) tail is added at the 3’ end of the mRNA. Ten different -thal mutations (Table 5) have 
been associated with defective polyadenylation due to mutations involving the consensus 
sequence AATAAA required for the cleavage-polyadenylation reaction. Mutations involving 
the polyadenylation signal are: seven base substitutions at different positions of the consensus 
sequence, two short deletions of 2 and 5 bp each, and one deletion of the total AATAAA 
sequence. These mutations markedly decrease the efficiency of the cleavage-polyadenylation 
process but do not abolish it completely so that the associated phenotype is that of +-thal of 
moderate severity.  
In the 3’ UTR region downstream of the termination codon, a C→G substitution at 
nucleotide 6, and a 13-bp deletion at nucleotides 90, also result in +-thal (50). 
Mutations resulting in premature termination of translation  
Approximately half the -thal alleles result from the introduction of premature 
termination codons, due to mutations creating a stop codon or to changes in the reading frame 
by insertion or deletion of a single or a few nucleotides. These frameshift defects cause 
premature termination further downstream when the next nonsense codon is reached (45,50). 
The AAG→TAG (Lys→Stop) at codon 17, and CAG→TAG (Gln→Stop) at codon 39 were 
the first nonsense mutations characterized and extensively studied. The former is was found 
in Chinese patients and the latter is the second most common cause of -thal in the 
Mediterranean population accounting for 95% of the cases of -thal in Sardinia.  
The frameshift and nonsense mutations, inherited as a typical recessive -thal 
character, result in premature termination within exon 1 and 2 with a couple of exceptions 
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terminating prematurely in exon 3 (45). In heterozygotes for such cases, no -chain is 
produced from the mutant allele, resulting in a typical asymptomatic phenotype. In contrast, 
in mutations that produce in-phase termination later in the -sequence, in exon 3, the mRNA 
does not undergo nonsense-mediated decay and produce normal amounts of mutant  mRNA, 
which presumably gets translated into variant -chains (62).  
Mutations affecting the initiation codon 
Nine mutations affecting the initiation codon (ATG) have been described and all 
produce  thal (Table 5). One mutation involves an insertion of 45 bp between positions –22 
and+23, thus affecting the initiation codon (63). The rest are single base substitutions, two 
affecting the first (A), three the second (T), and three the third (G) nucleotide of ATG. It is 
theoretically possible for mutant  mRNAs to be initiated at the next downstream initiation 
codons, which are located at codons 21 and 22 or codon 55.  
Deletions of the -glogin gene   
These deletions involve only the -globin gene and its flanking DNA without affecting 
any of the other -like globin of the cluster and range from 105 bp to approximately 67 kb in 
size (Fig. 15). The phenotype associated with these deletions is that of -thal. Two deletions 
remove the 3’ end but preserve the integrity of the 5’ end of the -globin gene. A 0.6-kb 
deletion involving the 3’ end of the -globin gene is a relatively common cause of -thal in 
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A recently described deletion, was present in compound heterozygosity with HbS in a 
patient from Cape Verde Islands affected by mild sickle cell disease (64). Such deletion 
removes 7.7 kb, starting in IVS2 of the -globin gene and extending 7.1 kb downstream, 
within the Kpn I family of L1 receptor elements. The other, rather rare deletions, are of 
particular functional and phenotypic interest. These differ in size, though are all located in the 
same region (from positions -125 to +78 relative to the mRNA cap site) in the  promoter, 
which includes the CACCC, CCAAT, and TATA elements. They are associated with 
unusually high levels of HbA2 and variable increases of HbF in heterozygotes. Codrington et 
al. (65) proposed that deletion of the  promoter removes competition for the upstream  
locus control region (LCR) and limiting transcription factors, thus allowing enhanced 
expression of the cis  and  genes. Carriers of these deletions have a variable and slight 
increases in HbF,though sufficient to partially compensate for the complete absence of -
globin in homozygotes as suggested by two individuals homozygous for different deletions in 
this group who are not transfusion dependent with a mild disease (45). 
 
1.4.1.2. Dominantly inherited -thalassemia (thalassemic structural variants) 
In this category are included the hyperunstable -globin chain structural variants that 
are synthesized at a normal rate but are so unstable that they are not able to form tetramers, 
thus resulting in a quantitative deficiency of -globin chains (1). Unlike the typical -thal, the 
hyperunstable -globin chain variants cause a disease phenotype even in heterozygotes, thus 
the alternative term, “dominantly inherited -thal.” Apart from the usual features of 
heterozygous -thal such as increased levels of HbA2 and decreased -globin chain synthesis, 
this group of -thal is characterized by severe dyserythropoiesis and intraerythroblastic 
inclusion bodies. Numerous dominantly inherited -thal alleles associated with similar 
clinical features have now been identified in families of disparate ethnic origins (1,45). Some 
are due to missense mutations in which the amino acid substitution is directly responsible for 
an unstable globin chain or mutants in which deletion or insertion of intact codons disrupts 
the structure. Others are caused by premature termination codons (nonsense mutations) in 
exon 3, which fail to undergo nonsense-mediated decay of the RNA. Frameshifts may also 
result in aberrant splicing producing elongated or truncated -globin chain variants with 
abnormal carboxy terminal ends (Table 6). 
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Figure 15. Deletions at the -globin gene. The L1 hatched box represents the 6.4 Kpn repeat 
3’ of the -globin gene. The horizontal black boxes represent deletions. The 3’ ends of three 
deletions (Vietnamese, Filipino, and Italian) have not been characterized as indicated by an 
arrow. The vertical shaded box represents the common region (from positions −175 to +128 
relative to the  mRNA CAP sites) lost in all the deletions except for the 619 bp (Asian 
Indian) and the 7.7 kb (Cape Verdean). The corresponding levels of HbA2 (%) and HbF (%) 




Table 6 shows 12 examples of variant Hb due to missense mutations. Hb Terre Haute 
(106 Leu→Arg) is a variant causing -thal intermedia is 41 This mutant, first described as 
Hb Indianapolis, was observed in members of two families in whom affected members had 
mild hemolytic anemia with 2%– 4% reticulocytosis, globin-chain biosynthesis with an 
/non- ratio of approximately 1.0 in bone marrow erythroblasts and of approximately 2.0 in 
peripheral blood reticulocytes. (67,68).  
In the example of Hb Chesterfield, an abnormal peak in the position expected for the -
globin chain variant but without detectable corresponding protein was demonstrated by 
globin-chain biosynthesis studies (69).  
Deletion or insertion of intact codons  
Nine examples of deletions or insertions of entire codons allow the reading frame to 
remain in phase, and the remaining amino acids are normal Table 6). Both Hb Korea and Hb 
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Gunma have 145 amino acid residues each; in Hb Gunma, the 127-128 Gln-Ala dipeptide is 
replaced by a Pro residue due to the deletion of three bases (AGG) (70); in Hb Korea, the 
deletion of three bases (GGT) removes one of the Val residues from codons 32–34 (71).  
Other -globin chain variants have extra residues and include the insertion of Arg in 
codons 30-31 and insertion of a single proline in codons 124-126. In all cases, no trace of 
abnormal hemoglobin could be detected by the standard techniques of IEF, high performance 
liquid chromatography, or heat stability tests. The mechanism that could explain the lack of 
detection of these structural -globin chain variants is that the affected amino acids are 
involved in 11 contacts. In the normal -globin chain, 30 Arg (B12), 33 Val (B15), 34 
Val (B16), 108 Asn (G10), 112 Cys (G14), 124 Pro (H2), 125 Pro (H3), 127 Gln (H5), 
and 128 Ala (H6) are essential for 11 dimer formation (43). Deletion or substitution of 
these critical amino acids would be likely to perturb, or even prevent, the formation of 11 
subunits and lead to the loss of about half of the -globin chains.  
Another example in this category involved a deletion of 12 nucleotides and an insertion 
of 6 nucleotides, leading to the substitution of the normal Val-Ala-Gly-Val by Gly- Arg in 
codons 134-137 and a -globin subunit that was two amino acids shorter than normal. 
Affected individuals of this Portuguese family had moderately severe anemia, splenomegaly, 
and leg ulcers (72). Another example of a hyperunstable  chain variant in this category is Hb 
Stara Zagnora (codons 137-139,  -6 bp) found in a Bulgarian by Efremov (73). A deletions of 
6 bp spanning codons 137-139 replaces Val-Ala-Asn with Asp and results in a hyperunstable 
variant associated with hemolysis and dyserythropoietic anemia with globin chain imbalance 
(/ synthesis ratio 1.40); HbA2 levels were normal. 
Premature termination (nonsense mutation) 
The GAA→TAA termination codon at codon 121, which leads to the synthesis of a 
truncated -globin chain is perhaps the most common dominantly inherited -thal allele. 
Significant amounts of mutant -globin mRNA were found in individuals with such 
mutations, showing the presence of the truncated -globin variant has been difficult (62).  
Elongated or truncated variants with abnormal carboxy terminal ends 
The elongated or truncated -globin variants in this group have arisen from frameshift 
mutations generating distal premature termination codons. Elongated β-globin subunits could 
also arise from aberrant splicing of precursor mRNA. As many as 24 different variants of this 
category have been described (Table 6).  
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1.4.2. The -thalassemia 
α-Thal is due to a decreased amount of α-globin chain synthesis. Unlike the β-globin 
chain, there are no developmental or adult substitutes for the α chain. Since two α globin 
genes are present in each haploid genome, mutations may occur in one to four alleles. Types 
and clinical forms of -thal thus depend on the number of affected genes (see Table 7).  
 









alleles of the -
globin chain 
Name of disease Symptoms 
4 0 Healthy 
individual 
Normal hematological profile 
3 1 -thalassemia 
silent carrier 
- Clinically asymptomatic 
- Blood test usually normal, 
hemoglobin normal 
- Slight changes in size of red 
blood cells (microcytic) 
- Slightly lighter color of red 
blood cell (hypochromic) 
2 2 -thalassemia 
trait 
- Mild anemia 
- Small red blood cells 
(microcytic) 
- Light, pale color of red blood 
cells (hypochromic) 
1 3 Hemoglobin 
H(HbH) disease 
- Moderate to severe anemia 
- Small red blood cells 
(microcytic) 
- Light, pale color of red blood 
cells (hypochromic) 
- Mild jaundice 
- Fatigue 
- Hepato-splenomegaly 
- Skeletal deformities (in some 
cases) 






- Intrauterine death of shortly after 
birth 
- Skeletal deformities 
- Cardiovascular problem 
- Improper brain growth 
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Figure 16. The Haemoglobin Bart's hydrops syndrome. a. peripheral blood film with 
immature red-cell precursors and hypochromic, microcytic, red cells showing anisocytosis 




The molecular basis of α-thal is now understood in great detail. Normally, the α-like 
genes are arranged along chromosome 16 in the order in which they are expressed in 
development (telomere-ζ2-α2-α1-centromere). Furthermore, it has been described that the 
cluster lies in a telomeric, gene-rich region of the genome, surrounded by widely expressed 
genes (see Fig. 7, page 9). Full expression of the α-like genes is critically dependent on the 
presence of a regulatory element (called HS-40), which lies 40 kb upstream of the cluster 
(toward the telomere). As many as 50 deletions removing one (-α/) or both (--) genes have 
been characterized and of these six (-α3.7/, -α4.2/, --SEA/, --MED/, -α20.5/ and --FIL/) represent 
by far the most common causes of α-thal worldwide. In addition, many different point 
mutations affecting the structural genes have been identified, these cause the less common 
nondeletional forms of α-thal (αTα/). This information has allowed researchers and 
hematologists to establish logical and robust screening programs for identifying patients with 
α-thal. This in turn allows clinicians to provide accurate genetic counseling and prenatal 
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diagnosis for the severe syndromes of α-thal, including Hb Bart’s Hydrops Fetalis and 
transfusion-dependent forms of HbH disease. When a mutation(s) completely abolishes 
expression from a chromosome this is called αo-thal and when the mutation(s) only partially 
downregulate expression from the chromosome this is called α+-thal (1,75) 
α+-thalassaemia due to deletions 
The α-globin genes are embedded within two highly homologous 4 kb duplication units 
[61-65]. One very common α-thal deletion is the rightward deletion, a 3.7 kb deletion caused 
by reciprocal recombination between Z segments producing a chromosome with only one 
functional α-gene (-α3.7 or rightward deletion) causing α-thal and an α-triplication allele 
without a thalassemic effect. Likewise a reciprocal recombination between mispaired X-
boxes results in a 4.2 kb deletion, called leftward deletion (-α4.2). An increasing number of 
deletions resulting in the loss of a single α-gene are reported due to non-homologous 
recombination events, most of which are rare, or highly region specific. 
α+-thalassemia due to non-deletion types of α-thalassemia  
-thal is more frequently caused by deletion than single point mutations or nucleotide 
insertions and deletions involving the canonical sequences controlling gene expression. In 
general, the non-deletion α+-thal determinants may give rise to a more severe reduction in α-
chain synthesis than the deletion type of chromosomes. Many mutations have been described 
affecting mRNA processing, mRNA translation, and α-globin stability. Of these the most 
common non-deletional variants are the αIVSI(-5nt)α (in Mediterraneans), polyadenylation 
site mutations α2AATAAG, α2AATGAA and α2AATA-- (in the Mediterranean and Middle 
East)[71-74], termination codon mutations leading to elongated Hb variants, such as Hb 
Constant Spring (HbCS), Hb Icaria, Hb Koya Dora, Hb Seal Rock and Hb Pakse (middle 
East, Mediterranean and South East Asia) and structural mutations causing highly unstable α-
globin variants; for example, Hb Quong Sze, Hb Suan Dok, Hb Petah Tikvah, Hb Adana, Hb 
Aghia Sophia . A regularly updated overview is provided by the HbVar web-site 
αo-thalassemia due to deletions 
The complete or partial deletion of both α-genes in cis results in no α-chain synthesis 
directed by these chromosomes in vivo. Homozygotes for such deletions have the Hb Bart's 
Hydrops Foetalis Syndrome. Many deletions were described which remove the ζ- and α-genes 
and although heterozygotes appear to develop normally, it is unlikely that homozygotes could 
survive even the early stages of gestation since neither embryonic (ζ2γ2) nor fetal (α2γ2) 
haemoglobins could be made. Rare deletions causing αo-thal remove the regulatory region, 
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which lies 40-50 kb upstream of the α-globin gene cluster leaving the α-genes intact. This 
region composed of four multispecies conserved sequences (MCS), called MCS-R1 to R4, 
correspond to the previously identified erythroid-specific DNAse1 hypersensitive sites 
referred to as HS-48, HS-40, HS-33 and HS-10. Of these elements, only MCS-R2 (HS-40), 
40 kb upstream from the ζ globin mRNA cap-site has been shown to be essential for α globin 
expression. Ethnic origin may guide molecular diagnosis. Knowledge of the mutations found 
in a specific population may allow strategic choice in laboratory diagnostics, especially in 
selection of the molecular techniques to be applied (75). 
In addition to these common forms of α-thal there are many rare and unusual molecular 
defects that have been identified. These are important because they provide an explanation for 
patients with hitherto undiagnosed anemia, and they help us to understand how the α cluster is 
normally regulated in vivo. Rarely, α-thal is caused by deletions that remove the α-globin 
regulatory element (HS-40). In general these mutations have been observed outside of the 
“malaria belt,” indicating that they are sporadic genetic events that have not been selected 
during evolution. These natural deletions first indicated the existence of this unexpected form 
of long-range control of α-globin expression. There are also two rare forms of α-thal that are 
found in association with a variety of developmental abnormalities, and in particular with 
mental retardation (so-called α-thal with mental retardation, ATR syndromes). The first group 
of patients has large (>1 Mb) deletions from the tip of chromosome 16 including the α-globin 
genes (ATR-16). These usually result from chromosome truncations or translocations and in 
fact this syndrome provided the first examples in human genetics of subcytogenetic 
chromosomal translocations, which are now known to underlie many cases of unexplained 
mental retardation. The second group of patients is now known to have mutations in a trans-
acting factor (called ATRX) encoded on the X-chromosome (ATR-X syndrome). These 
patients have α-thal with profound mental retardation, facial abnormalities, and urogenital 
anomalies. In this case it is thought that the X-encoded factor regulates expression of many 
genes, the α genes being but one target. Finally, there is a rare and unexplained form of α-thal 
that is seen as an acquired mutation in patients with myelodysplasia, hence called the 
ATMDS syndrome. 
These patients inherit a normal complement of α genes (αα/αα) but later in life develop 
myelodysplasia and presumably acquire a clonal genetic abnormality during the course of 
their disease. It is interesting that the majority of these patients are elderly males who at some 
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stage of their disease have abnormal erythropoiesis. It has recently been shown that these 
patients have acquired mutations in the ATRX gene (1). 
 
1.5. Distribution and prevalence of thalassemic hemoglobinopathies 
 
Just after World War II, independent studies in Italy and in Mediterranean immigrants 
in the United States highlighted a remarkably high frequency of thalassemia in these 
populations. This geographical association was in fact responsible for its naming (77,78). 
After these pioneering observations hundreds of publications demonstrated that thalassemia is 
a real global health problem (79).  
As shown in Fig. 17 and 18, it is clear that Hb disorders are not confined to any 
particular region, occurring widely across the world. It is established as well that the 
unusually high frequency of the Hb disorders is the result of natural selection due to the 
relative resistance of carriers against Plasmodium falciparum malaria (77). The unequal 
distribution of the different thalassemic genes in different countries reflects complex epistatic 
interactions between the genes for carriers for different varieties of these diseases with respect 
to the relative resistance of carriers to malaria (78,79). Other factors also help maintain the 
gene frequency for these conditions at a high level. These include: the practice of 
consanguineous marriage, the increased maternal age, gene drift and founder effects.  
Thalassemic genes have been identified across Southern Europe from Portugal to Spain, 
Italy and Greece, as well as in a number of central European countries and parts of the former 
Soviet Union. They also affect the Middle East through to Iran, Pakistan, India, Bangladesh, 
Thailand, Malaysia, Indonesia and southern China, as well as countries along the north coast 
of Africa and in South America.  
Hemoglobin disorders have spread through the migration of populations from endemic 
areas to countries where their prevalence in indigenous populations had been extremely low. 
Such countries include the USA, Canada, Australia, the United Kindom and France. 
Although reliable data are still lacking for many regions of the world, recent data 
indicate that about 7% of the world’s population is a carrier of an Hb disorder, and that 
300,000 to 500,000 children are born each year with the severe homozygous states of these 
diseases (76,80). 
The Hb variants of the greatest clinical significance are Hb S, C, and E. The Hb S gene 
has the greatest frequency in West Africa, where approximately 25% of individuals are 
47 
 
Dr. Le Phan Minh Triet:  Hemoglobinopathies in mountainous region of Thua Thien Hue, Vietnam   
Ph.D thesis in Biochemistry and Molecular Biology 
Ph.D School in Biomolecular and Biotechnological Sciences - University of Sassari 
 
heterozygous; the Mediterranean, Caribbean, South and Central American, Arab, and East 





Figure 17. The world distribution and different mutations that cause -thal. Those shown in 






Figure 18. The world distribution of the -thal. The o-thal is found at high frequencies in 
Asia and some Mediterranean countries. The +-thal have a much broader distribution. Some 
of the different subtypes of o- and +-thal are shown. --SEA indicates the Southeast Asian 
deletion form of o-thal -4.2 or -3.7 relate to different forms of +-thal with their particular 
deletion sizes, -3.7 is further subdivided into types I, II, and III, again depending on the 
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Figure 19. The world distribution of hemoglobins S and E (74). 
 
 





Other common Hb variants include Hb E and Hb C (Fig. 19 and Table 8). Hb E is the 
most common structural variant in the world. The distribution of Hb E extends from Eastern 
India through Southeast Asia and has its highest incidence in Thailand, Laos, and Cambodia. 
The highest frequency of the Hb E allele was reported in Eastern Thailand near the 
Vietnamese border, an area termed the ‘‘Hemoglobin E triangle’’, where the carrier rate is as 
high as 25% to 30%. The Hb E variant also is seen sporadically in parts of China and the 
Indonesian islands. In areas of the United States that have large populations of immigrants 
from Southeast Asia, this variant is found more commonly than Hb S in newborn-screening 
programs. Hb C is restricted to parts of West Africa and is estimated to have a gene frequency 





Dr. Le Phan Minh Triet:  Hemoglobinopathies in mountainous region of Thua Thien Hue, Vietnam   
Ph.D thesis in Biochemistry and Molecular Biology 
Ph.D School in Biomolecular and Biotechnological Sciences - University of Sassari 
 
1.5.1 Distribution of hemoglobinopathies in Southeast Asia and in Vietnam 
Southeast Asia consists of 10 countries with a total population of about 400 million. 
The ethnic origins of people living in these countries are very heterogeneous. The Mon-
Khmer and Tai language-speaking people occupy Thailand, Laos, Cambodia and some parts 
of Vietnam, Myanmar and Malaysia. The west includes the Burmese (Tibeto-Burman) and 
the Northeast is the Vietnamese (Austro-Asiatic). The Malayopolynesians (Austronesian) live 
in Malaysia, Indonesia, Brunei, the Philippines and a number of Pacific island nations. 
Chinese and Indians are relatively newcomers spread throughout the region.  
Hemoglobinopathies are the most common genetic disorders among the people living in 
Southeast Asia. In Southeast Asia α-thal, β-thal, Hb E and Hb Constant Spring (CS) are 
prevalent. The gene frequencies of α-thal reach 30-40% in Northern Thailand and Laos, 4.5% 
in Malaysia and 5% in the remote island of the Philippines, whereas β-thal vary between 1 
and 9%. Hb E is the hallmark of Southeast Asia attaining a frequency of 50-60% at the 
junction of Thailand, Laos, and Cambodia. Hb CS gene frequencies vary between 1 and 8%. 
These abnormal genes in different combinations lead to over 60 different thalassemia 
syndromes, making Southeast Asia the locality with the most complex thalassemia genotypes 
(83). 
In Vietnam, both β-thal and Hb E are prevalent and represent one of the most common 
forms of hemolytic anemia. Three-quarters of the population of more than 80 million are of 
the Kinh ethnic group, and the remaining comprise over 50 different minority ethnic groups. 
β-thal and Hb E are distributed in all regions in Vietnam. The carrier rate for β-thal varies 
between 1.5% and 25% (84). The higher incidence was in the ethnic minority groups, 
especially Tay (11%) and Moung (25%) in the North and Pako (8.33%) and Catu (14%) in 
the central region of the country. The prevalence of Hb E in Kinh groups was not much 
different throughout the country, 1–9%. The highest frequencies of Hb E were in the minority 
groups, Ede (41.7%), Pako (6%), and Van Kieu (23%) who live in the central plateau. The 
frequency of β-thal studied in the Kinh people and the Vietnamese refugees in the United 
States was between 1% and 2%, and Hb E in Saigon was about 3.2% (84,85). 
Table 9 estimates that more of 300,000 children are born each year with either 
thalassemia or sickle cell anemia in the world (81). One unexpected features of these data are 
the finding that the serious forms of -thal are almost equally divided between -thal major 
and HbE/-thal as the result of the extremely high frequency of HbE disorder in India, 
Bangladesh, Myanmar, and many other Southeastern Asia countries. The symptomatic forms 
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of -thal, HbH disease, and Hb Bart’s hydrops fetalis are also mainly confined to Southeast 
Asia.  
One of the most striking features of these data is the finding that the severe forms of -
thal are almost equally divided between -thal major and Hb E\-thal, which reflects the 
extremely high frequency of the latter disorder throughout Southeast Asia. The symptomatic 
forms of -thal, Hb H disease, and Hb Bart’s hydrops fetalis are also mainly confined to 
Southeast Asia. 
 




However, as suggested by Weatherall (79), these results must be reviewed with caution. 
Since large scale population surveys of the Hb variants were carried out on relatively small 
samples from limited numbers of centres in individual countries, they have to be considered 
as a rough approximation of the true global load of the thalassemias. More recent 
micromapping, which have achieved adequate sample-size estimates from many different 
parts of an individual country, have shown that there is a remarkable heterogeneity in the 
distribution of these conditions within populations separated by only short geographical 
distances (86,87). This is particularly clear from the result showed in Fig. 20, which resumes 
frequencies and heterogeneity of -thal mutations as the result of micromapping in Portugal, 
Spain, France, Italy and the island of Sardinia, Greece, Cyprus, United Kingdom. Similarly, 
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Figure 20. Heterogeneity and prevalence of the different -thal mutations in eigth European 
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Figure 21. Heterogeneity and prevalence of the different -thal mutations in Mediterranean. 
 
 
To provide a better estimate of the global burden of the Hb disorders, in the future it 
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2. RESEARCH OBJECTIVES 
 
In Vietnam, most of researches on hemoglobinopathies were mainly conducted in the 
North and the South regions. While this research was in progress, Nguyen et al. (89) 
performed a preliminary study on hemoglobinopathies in Thua Thien Hue Province, the 
central area of Vietnam, which was restricted to a limited number of pregnant women. 
Epidemiologic researches of hemoglobinopathies are, in general, not systematic and 
molecular studies concerning Vietnam are incomplete.  
Nam Dong and A Luoi, two mountainous districts of Thua Thien Hue Province have 
very poor socio-economic conditions and are inhabited mainly by ethnic minorities including 
Pako, Cotu, Taoi. People in these districts also face many risk factors for hemoglobinopathies 
such as malaria and consanguineous mating.  
With the aim to contribute to a better knowledge of thalassemia defects in Vietnam, 
with the additional goal to promote future national screening and prenatal diagnosis programs 
of the severe forms, this research was carried out with following objectives: 
1. Estimate the prevalence of hemoglobinopathies in the two mountainous Vietnamese 
districts of Thua Thien Hue: Nam Dong and A Luoi. 
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3. MATERIALS AND METHODS 
 
3.1. Study design 
This consisted with a cross-sectional study that was conducted in the period March 
2012 to June 2013. 
 
3.2. Study setting 
Thua Thien Hue is a province in the North Central Coast region of Vietnam, 
approximately in the center of the country. Thua Thien Hue is divided into one city (Hue), 
two towns (Huong Tra and Huong Thuy) and six districts (two of which mountainous). The 
research study was conducted in the mountainous districts of Nam Dong and A Luoi. 
3.2.1. Nam Dong district 
Nam Dong is located in highlands and bounded by Quang Nam province in the south, 




Figure 22. Map of the Nam Dong district. 
 
- Area: 661,95 km2 
- Sea level: 500 m 
- Population: 24.546 including Cotu, Kinh… 
- Capital: Khe Tre 
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- 10 communes: Huong Giang, Huong Hoa, Huong Huu, Huong Loc, Huong Phu, 
Huong Son, Thuong Lo, Thuong Long, Thuong Nhat, Thuong Quang. 
3.2.2. A Luoi district 
A Luoi is located west in the highly moutainous area of A Shau valley bordering Laos 
- Area: 1232,70 km2 
- Sea level: 700 m 
- Population: 45.546 including Taoi, Pako, Kinh, Cotu… 
- Capital: A Luoi 
- 20 communes: A Dot, A Ngo, A Roang, Bac Son, Dong Son, Hong Bac, Hong Ha, 
Hong Kim, Hong Quang, Hong Thai, Hong Thuong, Hong Thuy, Hong Trung, Hong 





Figure 23. Map of the A Luoi district. 
 
3.3. Population and sample 











Dr. Le Phan Minh Triet:  Hemoglobinopathies in mountainous region of Thua Thien Hue, Vietnam   
Ph.D thesis in Biochemistry and Molecular Biology 
Ph.D School in Biomolecular and Biotechnological Sciences - University of Sassari 
 
Where p: prevalence of disease, z: the upper α/2 point of the normal distribution, α: 
type I error (the error of rejecting a null hypothesis when it is actually true), Δ: one half the 
width of the desired sample confidence interval. 
With α= 0.05, 
2/ = 1.96; p = 12%, Δ = 0.02, α = 0.05, n = 1015 
 We decided to choose n= 1100 
There are 21 communes in A Luoi and 11 communes in Nam Dong. Sample size in 
each commune was proportional to its population size and its ethnic distribution. Samples 
were randomly selected. 
Table 10. Population and sample 
 A LUOI NAM DONG 
Commune Population Sample (n) Commune Population Sample (n) 
1 Hong Thuy 2,957 34 Thuong Quang 1,871 38 
2 Hong Van 2,723 35 Thuong Nhat 2,053 41 
3 Hong Trung 1,911 51 Thuong Long 2,429 47 
4 Bac Son 1,125 29 Thuong Lo 1,222 28 
5 A Roang 2,613 45 Khe Tre 4,005 31 
6 A Dot 2,247 41 Huong Son 1,382 31 
7 Dong Son 1,333 20 Huong Phu 3,066 24 
8 Huong Lam 1,999 36 Huong Loc 2,264 46 
9 Huong Phong 419 4 Huong Huu 2,546 50 
10 Phu Vinh 1,026 14 Huong Hoa 2,347 18 
11 Hong Thuong 2,192 25 Huong Giang 1,361 31 
12 Son Thuy 2,740 41    
13 A Ngo 3,080 48    
14 Nham 2,158 28    
15 Hong Thai 1,455 24    
16 Hong Quang 2,011 27    
17 Hong Bac 1,988 36    
18 Hong Kim 1,796 36    
19 A Luoi 6,965 100    
20 Hong Ha 1,629 22    
21 Huong Nguyen 1179 19    
Total 45,546 725  24,546 385 
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3.4. Methods 
3.4.1. Socio-demographic data collection 
The questionnaire for all participants were designed by study group. The final 
questionnaire collected data on demography: age, gender, ethnicity, geography. 
3.4.2. Laboratory examination 
Whole blood were collected using EDTA as anticoagulant. 
3.4.2.1. Complete blood count (CBC) 
Red blood cell indices and complete cell analysis were determined using an automated 
cell counter (Celldyn 3200, Abbott). We used following hematological parameters for the 
research: RBC (x10
12
/L), Hb (g/dL), MCV (fl), MCH (pg). Anemia cases were diagnosed by 
Hb concentration.  
 




The MCV and MCH levels are usually altered in Hb disorders. Samples with MCV < 
80 fl and or MCH < 27 pg were analyzed in the next step. 
3.4.2.2. Single tube osmotic fragility (OF) 
After pipetting 20 μL of fresh homogeneous EDTA blood into a tube containing 5 mL 
of a 0.34% and 0,35% NaCl solution, the suspension is gently shaken. In normal conditions, 
the suspension should become clear in few minutes (OF test negative). The continued 
presence of turbidity after 5 min indicates reduced OF (or elevated osmotic resistance) and 
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3.4.2.3. Hb electrophoresis 
Samples with one of following abnormal haematological parameters were analyzed by 
electrophoretic techniques: 
- Anemia 
- MCV < 80 fl 
- MCH < 27 pg 
- OF test positive 
 
Isoelectric focusing (IEF)  
This technique separates proteins according to their isoelectric points (pI). A stable pH 
gradient is established in the gel by the addition of appropriate ampholytes. A protein mixture 
is placed in a well on the gel. With an applied electric field, proteins enter the gel and migrate 
until each reaches a pH equivalent to its pI. This is because of when pH = pI, the net charge 
of a protein is zero (Fig. 24).  
 
Figure 24. The principle of isoelectric focusing. 
 
Immobilized pH gradient gels are acrylamide gel matrix co-polymerized with a pH 
gradient, which result in completely stable gradients except the most alkaline (>12) pH 
values. The immobilized pH gradient is obtained by the continuous change in the ratio of 
carrier ampholites.  
Ampholytes are weak acid or base defined by its pK value. All of the amino acids found 
in proteins are ampholytes because they contain a carboxyl group that acts as an acid and an 
amino group that acts as a base. They are used in IEF after co-polymerization with 
acrylamide. They set up a stable pH gradient through the electrophoretic medium, and 
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IEF is the most useful, and economical, technique for the separation of normal and 
abnormal hemoglobins (Fig. 25)(92). 
In this work, IEF was as follows: peripheral blood samples were collected in EDTA as 
anticoagulant and washed three times in 0.15 mol/1 NaCI by centrifugation at 1500 X g. 
Washed red cells were lysed with 7.7 mmol/1 K.CN in water and adjusted to a final 
concentration of 6-8 g/1 of Hb. Higher concentrations caused poor separations of Hb fractions 
in the IEF system. 125 X 125 X 0.5 mm poly- acrylamide gels, 15 wells capacity, or 125 X 
250 X 0.5 mm, 30-33 wells capacity, were cast onto silanized glass plates. 5% 
polyacrylamide gels were prepared by mixing 1.67 ml of 8.55 mol/1 acrylamide-0.06 mol/1 
bisacrylamide stock solution, 622 l Pharmalyte, pH 6.7-7.7 range (Pharmacia, Uppsala, 
Sweden), 50 /il Pharmalyte, pH 3.5-10, and 7.67 ml water. Polymerization was achieved by 
the addition of 16 l TEMED and 14 JU.I of 1.75 mol/1 ammonium persulfate. Anodic and 
cathodic solutions were 40 mmol/1 glutamic acid and 1 mol/1 NaOH, respectively. Gels were 
prerun for 45 min at 400 V. Lysates were applied at the cathodal site in a volume of 
approximately 5 /il in slots precast in the gel, and electrophoresis was for 90 min at 1600 V 
constant voltage on the Consort E 3800 apparatus. Multiplier cell (Pharmacia, Uppsala, 
Sweden) thermostated at 4°C. Electrophoretic migration was performed at 4
°
C with the 
refrigerated bath circulator Wise Circu

 WCR – P6 (Wisd – Daihan Scientific). Gels were 






Hb S [6(A3) Glu→Val] 
Glu has charge = -1
Normal HbA, with Glu at position 6, has charge = 0
Mutant HbS, with Val at the same position, lost that -1charge 
















Figure 25. Isoelectric focusing of hemoglobins of newborns and adults. 
 
Acid Urea Triton PolyAcrylamide Gel Electrophoresis (AUT-PAGE) 
It is a variant of the SDS polyacrilamide gel electrophoresis, thus separating on the 
basis of molecular weight, charge and, additionally, of the properties of the –R group. Since 
Triton X-100 is a nonionic surfactant, it denatures native proteins to unfolded individual 
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polypeptides by deleting hydrophobic interactions whereas mass and the net charge remains 
unchanged. It is largely used in the detection of Hb variants though it is not useful for variants 
due to charged amino acid substitutions (93).  
The method consists in a vertical polyacrylamide gel polymerized in the presence of 
8M urea with migration in a acetic acid solution and the presence of Triton X-100, a non-
ionic detergent which masks some charged residues.  
In this work, globin chains were separated by electrophoresison 12% polyacrylamide 
gels, containing 6 M urea and 2% Triton X-100, in 5% acetic acid. The gel solution consisted 
of 5 ml of 60:0.4% acrylamide: bis-acrylamidc (Eastman Kodak Company); 1-25 ml of 
glacial acetic acid; 18-75 ml of 8 M urea; 0.125 ml of Temed (NNN'N'-tetra-
methylcchylcncdiaminc); 0.5 ml of Triton X-100; and 15 mg of ammonium persulphate. The 
gel mixture was degassed by vacuum and then used for the gel.  
Slab gels were 12 cm long, 16 cm wide and 1.5 mm thick. The well-former had 12 
spaces. Gelling occurred within 30 min, but the gels were left for 2 h prior to use. The 
electrophoresis buffer was 5% acetic acid. The gels were pre-electrophoresed for 60 min at 
200 V with the anode at the top. The current fell from 60 mA to 40 mA. The anode buffer 
was removed, the gels were overlayed with 1 M -mercaptoethylamine. 
Fresh electrophoresis buffer was added and a second pre-electrophorcsis performed for 
45-60 min at 150 V. The current fell from 30 to 20 mA. The -mercaptoethylamine was then 
removed entirely. Sample buffer consisted of 5 ml of 8 M urea, 0.5 ml of glacial acetic acid, 
0.5 ml of 2-mercaptoethanol and 2 mg of pyronin Y. All procedures were performed at room 
temperature.  
The gels were stained for 30 min in 0.5% Coomassie Brilliant Blue, in 7% acetic acid, 
30% methanol, and destained in the acetic acid-methanol by diffusion.  
AUT-PAGE was performed with Protean

 II xi Cell and Power Supply HV (Biorad). 
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3.3.2.4. High Perfomance Liquid Chromatography (HPLC) 
High-performance liquid chromatography (sometimes referred to as high-pressure 
liquid chromatography), HPLC, is a chromatographic technique used to separate a mixture of 
compounds with the purpose of identifying, quantifying or purifying the individual 
components of the mixture. HPLC has many uses including medical (e.g. detecting vitamin D 
levels in blood serum), legal (e.g. detecting performance enhancement drugs in urine), 
research (e.g. separating the components of a complex biological sample, or of similar 
synthetic chemicals from each other), and manufacturing (e.g. during the production process 
of pharmaceutical and biological products). Several methods are used to separate normal and 
abnormal Hbs. 
As shown in Fig. 3.6, the stationary phase surface displays ionic functional groups (R-
X) that interact with analyte ions of opposite charge.  
This type of chromatography is further subdivided into cation exchange 
chromatography and anion exchange chromatography. The ionic compound consisting of the 
cationic species M
+
 and the anionic species B
-
 can be retained by the stationary phase. 
Cation exchange (CE) chromatography retains positively charged cations because the 









    R-X-M+  +  C+ + B
-
 





















 in the mobile phase can be adjusted to shift the 
equilibrium position and thus retention time. 
The abnormal samples identified by means of electrophoresis were analyzed by two 
different HPLC techniques. 
Cation Exchange – HPLC (CE-HPLC)  
Ion-exchange chromatography (or ion chromatography) is a process that exploits 
differences in the sign and magnitude of the net electric charges of proteins at a given pH. It 
can be used for almost any kind of charged molecule including large proteins, small 
nucleotides and amino acids. It is often used in protein purification, water analysis, and 
quality control.  
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Figure 27. The principle of chromatography. It is shown a typical chromatogram obtained 
with an anion exchange column. 
 
In this study, the Bio-Rad Variant, a fully automated HPLC system largely used in the 
search for hemoglobinopathies, was used. It employs the β Thalassemia Short program, 
designed to separate and determine in 5–6 min the area percentages for HbA2 and HbF and to 
provide qualitative determinations of abnormal Hbs. Windows for retention times have been 
established for presumptive identification of the most commonly occurring Hb variants. In 
Fig. 26 it is shown the chromatogram obtained separating Hb of a carrier of -thal. Note that 
the quality of Hb is as in normal, the only difference being the higher level of the HbA2. 
 
 
Figure 28. The Variant

 CE-HPLC chromatogram. Lysate was from a heterozygous -thal 
with increased HbA2. 
 
Reversed phase-HPLC (RP-HPLC)  
In the reversed phase-HPLC a non-polar stationary phase and an aqueous, moderately 
polar mobile phase are used. One common stationary phase is a silica which has been surface-
modified with R-Me2SiCl, where R is a straight chain alkyl group such as C18H37, C8H17, 
or C4H9. With such stationary phases, retention time is longer for molecules which are less 
polar, while polar molecules elute more readily (early in the analysis).  
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It is possible to increase retention times by adding more water to the mobile phase; 
thereby making the affinity of the hydrophobic analyte for the hydrophobic stationary phase 
stronger relative to the now more hydrophilic mobile phase. Similarly, it is possible to 
decrease retention time by adding more organic solvent to the eluent. RP-HPLC is so 
commonly used that it is often incorrectly referred to as "HPLC" without further 
specification.  
In this research, RP-HPLC was performed on a Vydac C4 column with a linear gradient 
of acetonitrile:water (from 20 to 60%) as described by Masala and Manca (94).  
Blood samples collected in anticoagulant are diluted with 4-5 volumes of saline (0.9% 
NaCl) and washed three times by centrifugation. Lysates are prepared by mixing a volume of 
the washed red cells with an equal volume of distilled water and 0.4 volumes CCl4, with 
occasional stirring. The mixture is centrifuged at 20,000 g for 10 min at 4°, and the clear Hb 
solution is collected using a pipette. An optimal separation occurs when a sample containing 
80-120 g globin is injected.  
Developer A is consistent with 200 ml Acetonitrile and 1 ml TFA, and water to 1000 
ml; Developer B contains 600 ml Acetonitrile and 1 ml TFA, and water to 1000 ml. 
The equipment consists of two pumps programmed with a controller, the Vydac C4 
column, an injector, a recorder, and a UV detector. The basic procedure is useful as a primary 
test on normal or abnormal adult and newborn lysates. The controller is programmed in order 
to create an 80 min linear gradient from 50 to 60% developer B (with a corresponding 
decrease in developer A from 50 to 40%) at the 1 ml/min flow rate. All procedures are carried 
out at room temperature.  
As shown in Fig. 29, the normal elution pattern shows the appearance of the most 
hydrophilic heme group, followed by a pre- peak, by the  chain of Hb A, by the G , the AT 
and the 
A chain of the Hb F. The AT globin is the product of an allele of the AI gene. Due to 
a point mutation, codon 75 may code for the Ile (
AI) or for Thr (AT).  
Variant globin chains having a substitution with a more hydrophobic amino acid elutes 
with a higher retention time. Globin having a substitution with a more hydrophilic amino acid 
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Figure 29. Separation of the globin chains of a newborn baby by RP-HPLC. Note the 
presence of a variant 
G gene. 
 
3.4.3. Detection of mutations affecting globin genes 
Selected samples indicating the presence of -thal gene(s) or variant Hbs, or both, were 
analysed in order to identify the affected gene and the mutation. 
DNA was extracted by the salting out method. This method involves salting out of the 
cellular proteins by dehydration and precipitation with a saturated NaCl solution.  
Buffy coats of nucleated cells obtained from anticoagulated blood (EDTA) were 
resuspended in 15 ml polypropylene centrifugation tubes with 8 ml of nuclei lysis buffer. The 
cell lysates were digested overnight at 37°C with 0.1 ml of 10% SDS and 0.5 ml of a protease 
K solution (1 mg protease K in 1% SDS and 2 mM Na2EDTA). After digestion was 
complete, 1 ml of saturated NaCl (approximately 6M) was added to each tube and shaken 
vigorously for 15 seconds, followed by centrifugation at 3000 rpm for 15 minutes. The 
precipitated protein pellet was left at the bottom of the tube and the supernatant containing the 
DNA was transferred to another 15 ml polypropylene tube. Exactly 1 volume of room 
temperature absolute isopropanol was added and the tubes inverted several times until the 
DNA precipitated. The precipitated DNA strands were removed with a plastic spatula or 
pipette and transferred to a 1.5 ml microcentrifuge tube containing 100-200 μl TE buffer . 
The DNA was allowed to dissolve 2 hours at 37°C before quantitating. (95). 
DNA was quantified with NanoDrop 8000 Spectrophotometer (Thermo Scientific) and 
DNA stored at -20
0
 C. 
Selected samples were amplified for target globin gene or portion of it (α, β, γ genes) 
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3.4.3.1. Amplification and isolation of α1 and α2 genes 
Selected amplifications of the entire α2 (2112 bp in length) and α1 loci (1753 bp) were 
performed using the α1α2 and α3α4 oligonucleotides. The PCR was carried out in a 50 μl 
reaction volume containing 200 ng genomic DNA, 0.3 μM of each primer, 375 μM dNTPs, 
2.0 mM MgCl2, 5% of DMSO, 0.07% of β-mercaptoethanol, 1 M betaine, 2.5 units Taq 
polymerase, in a 1X buffer (10X stock: 166 mM (NH4)2SO4, 670 mM TrisCl pH 8.8, 670 
μM Na2EDTA, 1.7 mg/ml BSA). 
The amplification reaction included 35 cycles of denaturation at 95°C for 1 minute, 
annealing at 60.6°C or 57°C (α2 and α1, respectively) for 1 minute, and extension at 72°C for 
3 minutes.  
Primers were the follows: 
PRIMER Position  LOCUS SEQUENCE (5’→ 3’) 
α1  32677- 32697  α2  AGCCTGGCCAAACCATCACTT 
α2  34770- 34788  α2  TTCTGAGCCACTGCCTGCA 
α3  36656- 36676  α1  GCTTTGTTTACCTGTTTAACC 
α4  38388- 38407  α1  AAAAACTCAGGCACACACAG 
3.4.3.2. Amplification and isolation of Gγ and Aγ genes 
Complete Gγ and Aγ genes were amplified with the same chemical and thermal 
protocol, except for the primer pairs. For sequence reactions nested PCR from these 
fragments were needed. 
Chemical protocol: 1X Buffer, 2 mM MgCl2, 375 μM dNTPs, 0.3 μM of each primer, 
1M Betaine, 0.2 μg of genomic DNA, 2.5 U of polymerase. Thermal file: 3’ at 95°C, 35 
cycles of 1’ at 95°C, 1’ at 52°C and 3’ at 72°C. 
Primers were the follows: 
PRIMER Position  LOCUS SEQUENCE (5’→ 3’) 
R159 38792- 38817      Aγ TGAAACTGTGGTCTTTATGAAAATTG 
R160 33855- 33880      Gγ GCACTGAAACTGTTGCTTTATAGGAT 
R161 34507- 34530 
39443- 39466    Gγ Aγ GGCGTCTGGACTAGGAGCTTATTG 
3.4.3.3. Amplification and isolation of β gene 
The complete β gene was directly amplified from genomic DNA with 3 different PCRs, 
each with its own chemical and thermal protocol. 
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-P1-P2 primers amplify a 706 bp region (-140 to +566) encompassing the proximal 
promoter to the beginning of IVS2. 
Chemical Protocol: 1X Buffer, 3.5 mM MgCl2, 250 μM dNTPs, 0.3 μM of each primer, 
0.3 μg of genomic DNA, 2.5 U of polymerase. Thermal file: 3’ at 95°C; 35 cycles of 1’ at 
95°C, 45’’ at 65°C and 1’ at 72°C; additional final extension was added (4’ at 74°C). 
-β7-β8 primers amplify a 923 bp region (+333 to +1255) including part of exon 2 and 
IVS2. This fragment contains also the Ava II polymorphism for Orkin Haplotypes (96). 
Chemical Protocol: 1X Buffer, 3 mM MgCl2, 250 μM dNTPs, 0.3 μM of each primer, 
0.3 μg of genomic DNA, 2.5 U of polymerase. Thermal file: 3’ at 95°C; 35 cycles of 1’ at 
95°C, 1’ at 60°C and 1’ at 72°C; additional final extension was added (4’ at 74°C). 
-β9-β10 primers amplify a 956 bp region (+799 to +1764) from IVS2 to 5’UTR of β-
gene. 
Chemical Protocol: 1X Buffer, 1.5 mM MgCl2, 250 μM dNTPs, 0.3 μM of each primer, 
0.3 μg of genomic DNA, 2.5 U of polymerase. Thermal file: 3’ at 95°C; 35 cycles of 1’ at 
95°C, 1’ at 55°C and 1’ at 72°C; additional final extension was added (4’ at 74°C). 
Primers were the follows: 
PRIMER Position  LOCUS SEQUENCE (5’→ 3’) 
β7 62469- 62489         β  TCCTGATGCTGTTATGGGCAA 
β8 63371-63391         β  AAAAGCAGAATGGTAGCTGGA 
β9 62935- 62955         β  AAAAACTTTACACAGTCTGCC 
β10 63881- 63900         β  ATTAGCTGTTTGCAGCCTCA 
3.4.3.4. Detection of Small Nucleotides Polymorphisms (SNPs) and 
microsatellites on the β-cluster 
To determin Orkin Haplotypes (96) configurations PCRs were set for each SNP or 
microsatellite. 
All the PCR contained 1X Buffer, 250 μM dNTPs, 0.3 μM of each primer, 0.3 μg of 
genomic DNA, 2.5 U of polymerase. MgCl2 was used at different concentrations (from 1.5 to 
4 mM). Thermal file was identical for all the PCR except for the annealing temperature (Ta): 
5’ at 95°C; 35 cycles of 1’ at 95°C, 1’ at Ta and 1’ at 72°C; additional final extension was 
added (4’ at 74°C). MgCl2 and annealing temperature can be found below. 
-HS2_F-HS2_R [3.5 mM MgCl2, Ta=57°C]: these primers amplify a fragment that 
contains the microsatellite (AT)xNy(AT)z in β-LCR-HS2. 
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-5pEpsilon_F-5pEpsilon_R [2.5 mM MgCl2, Ta=51°C]: this pair isolate a region 
upstream to the ε gene in which a Hinc II restriction (GTCAAC) site is present. 
-pseBeta_F-pseBeta_R [1.5 mM MgCl2, Ta=55°C] primers allowed to identify the 
Hinc II restriction site (GTTGAC) on  the ψβ1 gene. 
-3pseBeta_F-3pseBeta_R [3.5 − 4 mM MgCl2, Ta=55°C] isolate a region downstream 
the ψβ1 gene in which a Hinc II (GTTAAC) restriction site can be present. 
-proBeta_F-proBeta_R [3.5 mM MgCl2, Ta=51°C] primer pair amplify a portion of the 
distal promoter region of β-globin gene where (AT)xTy motif is present.  
-3pBetaBam_F-3pBetaBam_R [2.5 mM MgCl2, Ta=51°C] locate downstream the β-
globin gene, in which a Bam HI restriction site (GGATCC) is present. 
3.4.3.5. PCR fragment purification and quantification 
Following amplification, all the reaction volume was electrophoresed through a 1-1.2% 
agarose, 1X TAE, etidium bromurated gel at 7.5 volts/cm for 45 hour in presence of a 
molecular weight marker (Marker III, VI and 100 bp, Roche). Bands were visualized on an 
UV transilluminator, quantified by comparison with the marker and excised with sterile 
scalpel. 
DNA was recovered from agarose by means of the Montage Gel Extraction Kit 
(Millipore).  
3.4.3.6. Sequence Reaction 
The sequence reaction was performed by the BigDye Terminator v3.1 Cycle 
Sequencing Kit (Life Technologies). This kit is based on Sanger chain-terminating method 
and each terminator or dideoxyribonucleotide (ddNTP) is associated with a specific 
fluorochrome. Given that all 4 ddNTPs have different fluorochrome, the reaction can be 
performed in a single tube. 
The 20 μl reaction volume mixture consisted of: 2 μl of 5X Buffer, 2 μl of Mix, 3.2 
pmol of primer, 1-2 ng of PCR product per 100 bp. 
Sequence primers were almost always the same ones used in PCR; sometimes, because 
of the length of the fragment or other necessities, specific sequence primers were designed. 
Thermal file: 1’ at 96°C, 25 cycles of 10’’ at 96°C, 5’’ at 50°C and 4’ at 60°. 
Excess of unincorporated dye terminators and other contaminants (unincorporated 
primers, salts, and so on) were completely removed prior to electrophoresis through Sigma 
Spin Post-Reaction Clean-Up Columns (Sigma). 
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Purified sample was mixed with 2 volumes of formamide and injected on a 3130 
Genetic Analyzer (Life Technologies) capillary electrophoresis.  
3.4.3.7. Sequence analysis 
Sequence analysis was performed with the help of two software: Geospiza FinchTV 
(http://www.geospiza.com) and Another Plasmid Editor or APE (http://biologylabs.utah.edu/ 
jorgensen/wayned/ape/). 
FinchTV allowed to read and edit sequence files, while APE was used to align the 
obtained sequences with the reference β-globin cluster (AC #: U01317) and α-globin cluster 
(AC #: NG_000006).  
3.4.3.8. Multiplex Ligation-dependent Probe Amplification (MLPA) 
MLPA is a multiplex PCR method detecting abnormal copy numbers of up to 50 
different genomic DNA or RNA sequences, which is able to distinguish sequences differing 
in only one nucleotide (97).  
MLPA probes hybridise to the target, are legated together to form a ssDNA and are 
amplified by a single pair PCR primers. The resulting amplification produces marked 
fragments from 130 and 480 nt in length and can be analyzed by capillary electrophoresis. 
Comparing the peak pattern obtained to that of reference samples indicates which sequences 
show aberrant copy numbers (http://www.mrc-holland.com). 
MLPA P140HBA probemix (MRC-Holland) is designed to detect copy number changes 
of 24 different sequences in the  globin genes region. In addition, the probemix contains one 
probe that detects the presence of the Constant Spring mutation.  
In this study the MLPA reaction was performed with 100 ng of DNA and followed the 
provided protocol, with a 20 h hybridization. 
Data were analyzed with the Coffalyser.Net MLPA data analysis software available at 
the manufacturer’s website. 
 
3.5. Ethical issue 
The participants were explained about the research, its benefits and risks and asked to 
sign a consent to participate.  
Study protocols were approved by Hue University of Medicine and Pharmacy 
Institutional Review Board. The participants did not have to pay for this research. The results 
of the research was confidential. Participants with hemoglobinopathies received counselling 
about the risk factors and where to get medical support. 
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3.6. Statistical method 
Descriptive statistics including mean (±sd), proportions were calculated. Chi-square 
test and Fisher’s exact test were used to compare proportions and independent t-test was used 
to compare means of the continuous variables. Gene frequencies were calculated by using 
Hardy-Weinberg law. All reported confidence interval were two-sided 95% confidence 
intervals and p-values <0.05 were regarded as statistically significant. All analyses were 
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4.1. Demographic characteristics of the studied population 
 
Table 12. General demographic characteristics 
Ethnic Male Female Total 
Kinh 66 (6%) 113 (10.27%) 179 (16.27%) 
Pako 164 (14.91%) 206 (18.73%) 370 (33.64%) 
Taoi 86 (7.82%) 84 (7.64%) 170 (15.45%) 
Cotu 178 (16.18%) 200 (18.18%) 378 (34.36%) 
Pahy 0 1 (0.09%) 1 (0.09%) 
Muong 0 1 (0.09%) 1 (0.09%) 
Thanh 0 1 (0.09%) 1 (0.09%) 
Total 494 (44.91%) 606 (55.09%) 1100 (100%) 
 
Among 1100 participants, 494 (44.91%) were males and 606 (55.09%) were females; 
only 16,27% were Kinh and ethnic minorities, mainly the Cotu, the Pako, and the Taoi 
representing the remaining (83.73%) of the population (Table 12).  
 
Table 13. Demographic characteristics of each district 
Ethnic A LUOI NAM DONG 
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Of 715 participants in A Luoi, there are 45.45% males, 54.55% females. The Kinh 
ethnic group accounts for 13.99%, three main minority ethnic groups - the Pako, the Taoi and 
the Cotu account for the remaining (Table 14).  
In Nam Dong, there are 43.9% males, 56.1% females in a total of 385 participants. The 
Kinh ethnic group is 20.52%, the main minority ethnic group is the Cotu. 
 
Table 14. Age distribution 
Age (year) Male Female Total 
2-5 23 20 43 
6-14 72 66 138 
15-25 104 138 242 
26-40 147 231 378 
41-60 85 99 184 
>60 63 52 115 
Total 494 606 1100 
 
Age distribution is similar between genders. Average age is 32.7 ± 18.84, and range is 
from 2 years old to 102 years old. 
 
4.2. CBC and OF characteristics 
Tables 15 to 17 show haematological parameter and anemic cases found. 
Table 15. Mean value of hematological parameters 
Parameters Mean SD 
RBC 4.86 0.55 
Hb 13.34 1.48 
MCV 84.26 7.81 
MCH 27.65 2.99 
 
Table 16. Anemia rate of study group 
 Male Female Total 
Anemics 76 (6.91%) 104 (9.45%) 180 (16.36%) 
Normals 418 (38%) 502 (45.64%) 920 (83.64%) 
Total 494 (44.91%) 606 (55.09%) 1100 (100%) 
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Table 17. Anemia rate of the Kinh and the minority 
 Kinh Minority 
Anemics 30 (16.76%) 150 (16.29%) 
Normals 149 (83.24%) 771 (83.71%) 
Total 179 (100%) 921 (100%) 
 
Similarly, there is no difference in anemia prevalence between the Kinh (16.76%) and 
the minority (16.29%) (p > 0.05). 
731 samples which had one of the following signs: anemia, MCV < 80, MCH < 27, OF 
positive were screened by electrophoresis techniques. 
 
4.3. Electrophoresis and HPLC results 
Of the 731 abnormal samples defined above, 136 cases were diagnosed as being the 
carriers of hemoglobinopathies by the combination of methods: IEF, AUT-PAGE, CE-HPLC, 
RP-HPLC, including: Hb E, β-thalassemia and Hb Constant Spring (α thalassemia). 
 
Table 18. Hb E prevalence 
HbE n % 
Homozygous 3 0.27 
Heterozygous 111 10.09 
No 986 89.64 
Total 1100 100 
 
Two heterozygotes were found as being double heterozygotes Hb E/β thala. Hb E prevalence 
is 10.36% (10.09% heterozygous and 0.27% homozygous) 
 
4.4. Distribution of hemoglobinopathies among the Kinh and the minorities populations 
Results obtained indicate that the prevalence of the Hb E gene is 5 times higher in the 
minorities with respect to the Kinh population (Table 19). 
 
Table 19. Hb E prevalence between the Kinh and the minority group 
HbE Kinh Minorities 
 5 out of 174 
(2.79%) 
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Hb E prevalence in the ethnic minority group is statistically higher than that in the Kinh 
group with p < 0.0001: 11.83% versus 2.79%. 
Similarly, as shown in Table 20, Hb CS seems to be present only in the minority group. 
However, as already underlined, it is possible that the separation methods adopted in this 
work did not allowed the identification of all the carriers of the elongated globin chain. Thus, 
the difference between 2 groups is not statistically significant with p > 0.05. 
 
Table 20. Hb CS prevalence between the Kinh and the minority group 
Hb CS Kinh Minorities 
 0 5 out of 921 (0.54%) 
 
4.5. The molecular basis of the identified hemoglobinopathies  
Selected samples were analysed DNA to confirm genotype and describe type of 
mutation. β gene sequencing was carried out for Hb E and β-thalassemia cases. For Hb CS 
cases, the gene was α2.  
 
4.5.1. Hb E  
A total of six samples showing Hb E by the IEF, CE- and RP-HPLC were submitted to 
sequencing of the -globin genes. Three resulted E/, one E/E, and two E/o.  
Biochemicals aspects of a E/E subject are showed in Figg. 30 and 31, whereas that of a 
E/o are in Figg. 32 and 33. 
Sequencing confirmed that the G→A missense mutation at codon 26 (GAG→AAG) of 
the β globin gene, corresponding to the GluLys amino acid substitution, is responsible for 
Hb E (Fig. 34).   
.                                              
 
Figure 30. Electrophoresis of the lysate of a βE homozygote. The patient is in lane 3 of panel 
a) and in lane 6 of panel b). 
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Figure 31. RP-HPLC. Separation of the globin chains of the homozygous βE/βE. 
 
                   
Figure 32. Electrophoresis of the lysate of a βE/βo compound heterozygote. Panel a. IEF. 
Lanes 1, 2, 4: normal adults. Panel b. AUT-PAGE. Lane 1: normal adult; lane 2: normal 
newborn; lane 3: βE/βo; lanes 3,4,5,6: βE/β, lane 7: βE/βo. 
 
 
       
                      a.           b.  
 
Figure 33. HPLC separation of Hb and globin chains of the βE/βo compound heterozygote. 
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Hb E. Panel b): Reversed-phase HPLC showing the absence of  chains and the presence of 
the E globin and of the two different  chains of Hb F. 
The GAG→AAG mutation also affects the β-globin gene expression creating an 
alternate splicing site in the precursor mRNA at codons 25-27 of the β-globin gene. Thus, the 
formation of functional E-mRNA is decreased due to abnormal alternative splicing of 
precursor -mRNA at a site 5' to the IVS-I. As the result, the Hb E heterozygote is mildly 
affected and the homozygosity is a benign disorder with a mild -globin chain deficit which 
is comparable to that seen in a o-thal heterozygote. However, compound heterozygotes are 
often severely affected despite an increased production of Hb F scan be observed. Moreover, 
this variant has a weak interaction between α and β globin, causing instability when there is a 




Figure 34. Sequencing of the -genes of an homozigous for the Hb E. It is shown the: 
GAG→AAG at Codon 26 corresponding to the GluLys substitution. 
 
 
Patients having the E/E and E/o genotype were clinically similar to patients with -
thal of intermediate severity as described elsewhere (1).  
 
4.5.2. β-thalassemia  
5 cases were analyzed by the β-globin gene sequencing. Three were heterozygous and 
were identified thanks to the minor Hb A2 level determination by CE-HPLC (Fig. 35) 
whereas two were identified as o/E compound heterozygotes. 
Four different mutations giving rise to the o-thal (i.e. absent -globin chain synthesis 
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Figure 35. The typical CE chromatogram of the hemoglobins of a -thal heterozygote. It is 
evident the clearly increased level of the Hb A2. 
 
Table 21. o-thal mutations 
Sample -Genotypes o-thal mutation 
AL19 E/0 
cod 17 AAGTAG 
(LysStop)  
ST38 0/ 
cod 17 AAGTAG 
(LysStop)  
*BS11 E/0 IVS I-1 (GT)   
HV10 0/ –TTCT cod. 41/42 
HV2 0/ +G cod 14/15  
*The subject was homozygous for the C→T substitution in the promoter region of the G 
gene, at position -158 with respect to the Cap site (also known as the XmnI polymorphism). 
 
 
Two -globin genes carried the AAGTAG non-sense mutation at codon 17 
(LysStop) which is responsible for the premature interruption of the mRNA translation 
(Codon 17 (AT); AAG(Lys)TAG(stop codon) o, or  17(A14) LysStop (HGVS 
name: HBB:c.52A>T). This mutation was to first to be described at the molecular level in 
Chinese people in 1979 (98).  
One patient with Hb E was also the carrier of the GT substitution at the level of the 
invariant “donor” GT dinucleotides at the first nucleotide of the IVS I, which is essential for 
the splicing of introns. This patient was also the carrier of the Hb E mutation (IVS-I-1 
(GT); AG^GTTGGTAGTTTGGT o, or  nt 143 GT) (HGVS name: 
HBB:c.92+1G>T) (99). His genotype was thus β0/βE. Hematological parameters (RBC 
5.35x10
12
/L, Hb 9.3 g/dL, MCV 59 fl, MCH 17.4 pg) and the presence of 25.3% of Hb F 
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prompted the sequence of the -globin genes to be analysed. The C→T substitution, at 
position -158 with respect to the Cap site, in the promoter region of both the 
G gene (also 
known as the XmnI polymorphism) was found. This is a further evidence of an increased Hb 
F synthesis, during erythropoietic stress, under the control of this mutation (44).  
One patient was the carrier of the 4 bp (-TTCT) deletion at the level of codons 41/42 
which is responsible for a frameshift mutation resulting in a stop codon at the new codon 59 
terminating translation (TTCTTT(Phe-Phe)TT o, (Codons 41/42 (-TTCT); TTCTTT(Phe-
Phe)----TT o, or  41-42 (-TTCT); modified C-terminal sequence) (HGVS name: 
HBB:c.126_129delCTTT). It is a typical o-thal heterozygote with modest anemia, 
microcytosis, and hypochromia, usually transfusion-dependent in homozygotes (100). 
Finally, one subject was found to be heterozygote for the insertion of a nt (+G) at 
codons 14/15 (CTG TGG, Leu;Trp) CTG G TGG. The insertion modifies the C-terminal 
sequence: (15)Val-Gly-Gln-Gly-Glu-Arg-(21)Gly-COOH creating a stop codon at position 22 
(HGVS name: HBB:c.45_46insG) (101) 
 
4.5.3. Hb Constant Spring  
By the two electrophoretic techniques and the two HPLC, 5 subjects were identified as 
having small amounts of an abnormal Hb migrating close to the minor Hb A2 by IEF and CE-
HPLC (Figg. 36 and 37).   
Sequencing of the -globin genes of four subjects showing the (possible) Hb Constant 
Spring showed the expected mutation at the level of 2 gene at codon 142: TAA (stop codon) 
→CAA, (2 142, Stop→Gln; modified C-terminal sequence: (142)Gln-Ala-Gly-Ala-Ser-Val-
Ala-Val-Pro-Pro-Ala-Arg-Trp-Ala-Ser-Gln-Arg-Ala-Leu-Leu-Pro-Ser-Leu-His-Arg-Pro-Phe-
Leu-Val-Phe-(172)Glu-COOH) (HGVS name: HBA2:c.427T>C). This T→C mutation thus 
results in an extension of the  globin chain with 31 amino acid residues; a stop codon is 
found at the new codon 173. The globin chain is synthesized at a lower rate (102).  
Hematologic parameters of a homozygote were: RBC 4.71x10
12
/L, Hb 12 g/dL, MCV 
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Figure 36. Electrophoresis of a minor Hb variant. Panel a): IEF. Lanes 1 and 2: normal 
adults; lane 3: αCSα/αCSα. Panel b): AUT-PAGE. Lane 1: normal adult; lane 2: normal 
newborn; lane 3 αCSα/αα and lane 4: αCSα/αCS. 
 
 
a)             b)  
 
Figure 37. HPLC of the lysate of a subject with the αCSα/αCSα genotype. Panel a): CE-HPLC 
of the Hb tetramers. Panel b): RP-HPLC of globin chains.  
 
 
4.5.4. Haplotyping of the -globin genes cluster 
The assessment of the linkage of -thal and Hb E mutations and -globin gene 
polymorphisms with DNA polymorphisms in -globin gene cluster after Orkin et al. (96) was 
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- + - + - + + recombinant 
+ - - - - + + I 
 
2. E/ -/- +/+ -/- +/+ -/- +/+ +/+ recombinant 
 
3. E/ 
- + - + - + + recombinant  
+ - - - - - + VII 
 
4. E/0 
IVS I-1  





+ - - - - + + I 









cod 17  
+ - - - - + + I  
- + + - - - + VI 
 
 
Result of Table 22 suggests that -globin gene cluster carrying the E mutation is rather 
polymorphic since at least two different haplotypes cohexist in this limited sample: the 
haplotype I as described by Orkin et al. (96) (found in one chromosome) and another which 
may be the result of recombinations at the level of polymorphic sites of the haplotype I (four 
chromosomes). The same conclusion was made by others (103) in six Vietnamese families 
living in South Carolina (USA) and in unselected peoples originating from Cambodia, Laos 
and Thailand (104) indicating a multiple origins of the E-globin gene mutation that 
contributed to its high frequency in South East Asia.  
By analysis of restriction enzyme polymorphism this study obtained the expected 
evidence for the existence of at least four haplotypes: I, VI and VII and a recombinant, in cis 
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From March, 2012 to July, 2012, 1100 people (715 from A Luoi and 385 from Nam 
Dong) were enrolled. This is the largest community study on hemoglobinopathy in Central 
Vietnam. Recently, Nguyen et al. (89) conducted a similar study among pregnant women in 
Thua Thien Hue with a smaller scale (n = 410). In 2010, another study was conducted in 
South Vietnam by O’Riordan et al. (108) with a sample size of approximately 9000. Other 
studies were mainly carried out in patients in clinics with a small sample size or in limited 
families living abroad. 
In this study, 16.27% of participants were of the Kinh ethnicity and 83.73% belong to 
minority groups. This proportion corresponds with the demographic characteristics of the area 
under study although the Kinh make up 80-85% of the population in Vietnam. Three main 
ethnic minorities of the sample are Cotu (34.36%), Pako (33.64%) and Taoi (15.45%). The 
sample was representative for the community in Nam Dong and A Luoi.  
The anemia prevalence resulted 16.36%, which is relatively high in comparison with 
the prevalence found in other regions. Beside hemoglobinopathy, common causes of anemia 
are iron deficiency and parasite (hookworm). No difference was found in anemia prevalence 
by gender or ethnicity. 
MCV, MCH are 2 important parameters in hemoglobinopathy. MCV and MCH are low 
in patients with hypochromic microcytic anemia as is the case of hemoglobinopathies. 
Osmotic fragility (OF) test was the first method used for screening of thalassemia and 
was introduced as a simple approach to detect carriers by Silvestroni and Bianco in the 1940s. 
This fast and simple method has been applied as a screening test in large populations (105). 
Because of time and financial limits in this study Hb concentration, MCV, MCH and 
OF was helpful as the first step of screening. On the basis of those parameters, as many as 
731 samples were continuously screened by electrophoresis techniques and then HPLC and 
sequencing of the globin genes. 
The quite high 10.36% prevalence of the Hb E thalassemic variant was found which 
confirms it is the most common cause of hemoglobinopathies in South East Asia. The already 
discussed financial limitations did not allowed to performe CE-HPLC chromatography as a 
routine test so that many carriers of the low level Hb Constant Spring escaped from the 
observation in the electrophoretic methods. Thus, the 0.45% prevalence of the elongated 
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thalassemic variant is certainly largely underestimated as demonstrated by the observatyion of 
four homozygotes versus only one heterozygote.  
For the same reasons it was no possible to calculate the prevalence of β-thal because the 
corrected diagnosis is possible only after the determination of the minor Hb A2 which is the 
only parameter which allow the discriminanation of -thal and -thal. Few cases were 
identified because of in double heterozygosity with Hb E and other were selected because 
under treatment in the local hospital.  
Hb E, the most common Hb variant among Southeast Asian populations results from a 
G to A substitution at codon 26 (GAG→AAG) in exon 1 of the β-globin gene. Hb E confers a 
survival advantage against Plasmodium falciparum and could be the logical explanation for 
its high global prevalence. It is the most prevalent abnormal hemoglobin in South East Asia 
with its frequency approaching 60% in Northeast regions of Thailand, Laos and Cambodia. 
Significant numbers were reported from other Asia countries such as Srilanka, North Eastern 
India, Bangladesh, Nepal, Vietnam and Malaysia. Additionally, population transmigration led 
to its emergence in United States and Canada (106, 107). The 10.36% prevalence obtained in 
this study is also relatively high and there are two main reasons to explain this prevalence: 
malaria is still in circulation in Nam Dong and A Luoi Districts and consanguineous marriage 
largely occurs in the minority groups. 
Hb E occurs both in homozygous (EE) and heterozygous (EA or E trait) states and may 
co-inherits with α and β-thal, Hb S, Hb C and other hemoglobin variants. Hb EE and E trait 
are mild disorders and are associated with either mild or no anemia. In contrast, Hb E/β-
thalassemia displayed a remarkable variability in its clinical severity from mildly 
asymptomatic state to a severe transfusion dependent anemia. This is because of the major 
mechanism underlying the pathophysiology of Hb E/β-thal is consistent with the inadequate 
or absent β-globin chain production.  
The Hb E is a form of β+ phenotype and the remainder of the 4 mutations account for β0 
phenotype in affected individuals. The Hb E frequency was highest. In our study, the βE gene 
frequency was 0.0532 (0.0608 in the minority groups and 0.0014 in the Kinh group). The 
difference between the Kinh and the minority was significant. 
Table 23 compares the βE gene frequency described in South Vietnam, Central 
Vietnam (89, 108) and in this study. The frequency in the Kinh group obtained in this study is 
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Table 23. Comparison of βE gene frequency in South Vietnam and Central Vietnam 
Population βE gene frequency 
 
South Vietnam 










(Nguyen et al ) (89) 
Pregnant women 






Minority (Taoi, Cotu, Pako) 0.0608 
 
 
Some discrepancies is seen in comparison with that found in Dao, Tay, Nung but 
lower than that of the S’Tieng, the M’Nong, the Raclay, the Ede (108).  
As a whole, the βE gene frequency found in this study is lower than that in Southeast 
Asian populations (Table 24).  
 
Table 24. Comparison of βE gene frequency in Southeast Asian populations 
Population βE gene frequency 
 
Eight Southeast Asian 
populations 
(Laig M et al) (109) 
Karachi 0.507 
Ahom 0.342 
Northern Thailand 0.048 
Tak 0.102 
Khonkhaen 0.263 
Ubol Rachathani 0.287 
Cambodia 0.229 




Minority (Taoi, Cotu, Pako) 0.0608 
 
 
Besides Hb E (which has the phonotype of a mild +-thal), four different mutations at 
the β-globin gene were found, all giving rise to the absence of -globin production (o-thal): 
the AAG→TAG nonsense mutation at codon 17 (98), the G→T transversion at nt 1 of the 
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IVS-I (99), the four bp deletion (-TTCT) at codons 41/42 (100), and G insertion at codons 
14/15 (101).  
 


















Codon 26 (GAG→AAG) + + + + + 
Codon 17 (AAG→TAG) + + + + + 
Codons 41/42(-TTCT) + + + + + 
IVS-I-1 (G→T) + - + + - 
Codon 14/15(+G) + - - + - 
Codon 95 (+A) - + + - - 
Codons 71/72 (+A) - + + + + 
IVS-II-654 (C→T) - - + + + 
-28 (A→G) - - + + + 
Codon 19 (A→G) - - - + - 
Codon 35 (C→A)  - - - + - 
-86 (C→G) - - - + - 
IVS-I-5 (G→C) - - - - + 
 
There common mutations were found in all there regions of Vietnam, Thailand and 
China were Codon 26 (GAG→AAG), codon 17 (AAG→TAG) and codon 41/42(-TTCT). 
The common β-thalassemia in Southeast Asia have mutations of codon 17 (AAG→TAG), 
41/42 (-TTCT), 71/72 (+A) and IVS-I-1(G→T). Moreover, one of the most common point 
mutations in the β-globin gene is known as Hb E (β codon 26, GAG→AAG, Glu→Lys) 
(112). Previous studies in different areas of Thailand have shown that 70-90% of β-
thalassemia mutations are either frameshift codon 41/42(-TTCT) or nonsense codon 17 
(AAG→TAG), both causing β0-thalassemia (113).  
The frameshift mutation at codon 41/42(-TTCT) is the most common mutation in 
South and Southeast China where its frequency reaches above 40%. The nonsense mutation at 
codon 17 (AAG→TAG) has a high prevalence in Southern Chinese provinces as well as in 
North Thailand (110). These three mutations also had highest frequencies in North and South 
Vietnam (84,110,111). Two mutations found in North Vietnam (codon 95, +A) and codons 
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71/72, +A) and two found in South Vietnam (IVS-II-654 (C→T), -28 (A→G) were not 
observed in this study. The mutation of IVS-I-1 (G→T) was found in Central and South 
Vietnam but not found in North Vietnam. 
Mutation at codons 14/15 (insertion of G), was unobserved previously in Vietnam. In 
1988, Chan et al. (101) detected a new frameshift due to an insertion of G between codons 
14/15 of the β-globin gene in 2 unrelated Chinese patients with Cooley’s anemia. As shown 
in Table 25, this mutation was found in this study and in Thailand and it is not common in β-
thal. patients. This insertion of a nucleotide (+G) between codons 14 and 15 of the β-globin 
gene causes a frameshift mutation that results in premature termination 20 bp downstream. 
This accounts for the β0 phenotype in affected individual. In our study, the patients who gets 
this mutation is a Kinh male, 45 years old at A Luoi district, genotype β0/ β with Hb A2 4.6%. 
In this research -thal was not investigated. However, application of the 
electrophoretic analysis on all samples with anemia allowed the Hb Constant Spring to be 
identified in some subjects. This is a variant of the α2 gene having the stop codon 142 TAA 
mutated in CAA, coding Gln. Four cases had genotype αCSα/ αCSα and one case with αCSα/ 
αα. The production of an elongated globin is lower than the normal so that this disease 
expresses as a non-deletional α+-thal.  
The main area of the distribution of Hb CS is Southeast Asia. The Hb CS gene 
frequency was 0.033 in Northern Thailand and approximately 0.01 in Central Thailand and 
Cambodia. High frequencies between 0.05 and 0.06, were observed in Northeastern Thailand. 
A study in Laotians suggest that the Lao-speaking populations of the Mekong river basin in 
Northeastern Thailand and Laos have the highest frequencies of the Hb CS in Southeast Asia 
(109, 114).  
The αCS gene frequency of the minority group in this study was not possible to 
calculate. Previous studies indicated that differences exist in the prevalence of this mutation 
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Table 26. Comparison of αCS gene frequency in South Vietnam, Central Vietnam 
Population αCS gene frequency 
 
South Vietnam 






(Nguyen et al ) (89) 
Pregnant women 





Minority (Taoi, Cotu, Pako) present 
 
 
Table 27. Comparison of αCS gene frequency in Southeast Asian populations 
Population αCS gene frequency 
 
Eight Southeast Asian 
populations 
(Laig M et al) (109) 
Karachi 0 
Ahom 0 
Northern Thailand 0.0331 
Tak 0.0156 
Khonkhaen 0.0558 
Ubol Rachathani 0.0556 
Cambodia 0.0088 
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